Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
- Advised theses.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Fahrleitner-Pammer Astrid |

Publications

** = Publications listed in SCI/SSCI/Pubmed

2023

Full paper/article (Journal)

** Cejka, D; Wakolbinger-Habel, R; Zitt, E; Fahrleitner-Pammer, A; Amrein, K; Dimai, HP; Muschitz, C Diagnosis and treatment of osteoporosis in patients with chronic kidney disease Joint guidelines of the Austrian Society for Bone and Mineral Research (oGKM), the Austrian Society of Physical and Rehabilitation Medicine (oGPMR) and the Austrian Society of Nephrology (oGN)
WIEN MED WOCHENSCHR. 2023; Doi: 10.1007/s10354-022-00989-0
Web of Science PubMed FullText FullText_MUG

2022

Full paper/article (Journal)

** Dimai, HP; Johansson, H; Harvey, NC; Lorentzon, M; Liu, E; Vandenput, L; Fahrleitner-Pammer, A; Pietschmann, P; Muschitz, C; McCloskey, EV; Kanis, JA Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk.
Arch Osteoporos. 2022; 17(1): 141 Doi: 10.1007/s11657-022-01175-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Langdahl, B; Hofbauer, LC; Ferrari, S; Wang, ZX; Fahrleitner-Pammer, A; Gielen, E; Lakatos, P; Czerwinski, E; Gimeno, EJ; Timoshanko, J; Oates, M; Libanati, C Romosozumab efficacy and safety in European patients enrolled in the FRAME trial
OSTEOPOROSIS INT. 2022; Doi: 10.1007/s00198-022-06544-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Malle, O; Bergthaler, M; Krisper, P; Amrein, K; Dimai, HP; Kirsch, AH; Rosenkranz, AR; Pieber, T; Obermayer-Pietsch, B; Fahrleitner-Pammer, A Usefulness of the trabecular bone score in maintenance dialysis patients : A single center observational study.
Wien Klin Wochenschr. 2022; 134(11-12):442-448 Doi: 10.1007/s00508-022-02011-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Review

** Dimai, HP; Fahrleitner-Pammer, A Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions.
Best Pract Res Clin Rheumatol. 2022; 101780 Doi: 10.1016/j.berh.2022.101780
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Dimai, HP; Reichardt, B; Zitt, E; Concin, H; Malle, O; Fahrleitner-Pammer, A; Brozek, W Thirty Years of Hip Fracture Incidence in Austria; is the Worst Over?
J BONE MINER RES. 2022; 37: 139-140.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research (ASBMR); OCT 01-04, 2021; San Diego, CA. [Poster]
Web of Science

Abstract (Proceedings)

** Dimai, HP; Reichardt, B; Zitt, E; Concin, H; Malle, O; Fahrleitner-Pammer, A; Svedbom, A; Brozek, W Thirty years of hip fracture incidence in Austria: is the worst over?
Osteoporos Int. 2022; 33(1):97-104 Doi: 10.1007/s00198-021-06086-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2021

Full paper/article (Journal)

** Malle, O; Borgstroem, F; Fahrleitner-Pammer, A; Svedbom, A; Dimai, SV; Dimai, HP Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture - results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
Bone. 2021; 142:115071 Doi: 10.1016/j.bone.2019.115071 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Malle, O; Maurer, D; Wagner, D; Schnedl, C; Amrein, S; Pieber, T; Fahrleitner-Pammer, A; Dimai, HP; Amrein, K Morphometric parameters of muscle and bone in critically ill patients : Post hoc analysis of the VITdAL-ICU trial.
Wien Klin Wochenschr. 2021; 133(11-12):529-535 Doi: 10.1007/s00508-020-01736-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bytyqi, K; Baumann, PM; Hochfellner, D; Aberer, F; Simic, A; Treiber, G; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Beck, P; Mader, J Feasibility to use a continuous glucose monitoring system to manage diabetes during hospitalisation
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):211-212.-49. Jahrestagung ÖDG; NOV 18-20; Salzburg, AUSTRIA. [Poster]
Web of Science

** Dimai, HP; Reichardt, B; Zitt, E; Concin, H; Malle, O; Fahrleitner-Pammer, A; Svedbom, A; Brozek, W THIRTY YEARS OF HIP FRACTURE IN AUSTRIA; IS THE WORST OVER?
OSTEOPOROSIS INT. 2021; 32(SUPPL 1):S370-S371. [Poster]
Web of Science

** Hochfellner, DA; Baumann, PM; Aberer, F; Simic, A; Bytyqi, L; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Pieber, TR; Beck, P; Mader, J Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):209-209. [Poster]
Web of Science

** Langdahl, B; Hofbauer, LC; Ferrari, SL; Wang, Z; Fahrleitner-Pammer, A; Gielen, E; Lakatos, P; Czerwinski, E; Jodar-Gimeno, E; Timoshanko, J; Oates, M; Libanati, C ROMOSOZUMAB EFFICACY AND SAFETY IN EUROPEAN PATIENTS: A SUBANALYSIS OF THE PHASE 3, RANDOMISED FRAME STUDY
OSTEOPOROSIS INT. 2021; 32(SUPPL 1): S45-S46.
Web of Science

2020

Full paper/article (Journal)

** Body, JJ; Marin, F; Kendler, DL; Zerbini, CAF; López-Romero, P; Möricke, R; Casado, E; Fahrleitner-Pammer, A; Stepan, JJ; Lespessailles, E; Minisola, S; Geusens, P Efficacy of teriparatide compared with risedronate on FRAX^®-defined major osteoporotic fractures: results of the VERO clinical trial.
Osteoporos Int. 2020; 31(10):1935-1942 Doi: 10.1007/s00198-020-05463-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Geusens, P; Kendler, DL; Fahrleitner-Pammer, A; López-Romero, P; Marin, F Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial.
Calcif Tissue Int. 2020; 106(6):646-654 Doi: 10.1007/s00223-020-00683-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Haberl, HC; Pottler, T; Hochfellner, D; Aberer, F; Ziko, H; Simic, A; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK Evaluation of the Sensor Performance of a blinded, professional continuous Glucose Measurement System in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S360-S360.-Jahrestagung der österreichischen Diabetesgesellschaft ; [Poster]
Web of Science

** Haberl, HC; Pottler, T; Hochfellner, DA; Aberer, F; Ziko, H; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK Assessment of sensor performance of a blinded professional continuous glucose monitoring system in hospitalised patients with type 2 diabetes.
DIABETOLOGIA. 2020; 63(SUPPL 1):S348-S349.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

** Malle, OM; Fahrleitner-Pammer, AF; Dimai, HP IMPACT OF OSTEOPOROSIS TREATMENT ON QUALITY OF LIFE (QOL) AFTER FRAGILITY FRACTURE
OSTEOPOROSIS INT. 2020; 31(SUPPL 1):S429-S429. [Poster]
Web of Science

** Verheyen, N; Schmid, J; Kolesnik, E; Bencic, D; Kattnig, L; Scherr, D; Manninger, M; Fruhwald, F; Obermayer-Pietsch, B; Fahrleitner-Pammer, A; Zirlik, A; von Lewinski, D; Ablasser, K Prevalence and determinants of bone disease in patients with chronic heart failure-a prospective cohort study.
WIEN KLIN WOCHENSCHR. 2020; 132: S234-S235. [Poster]
Web of Science FullText

2019

Full paper/article (Journal)

** Bilezikian, JP; Lin, CJF; Brown, JP; Wang, AT; Yin, X; Ebeling, PR; Fahrleitner-Pammer, A; Franek, E; Gilchrist, N; Miller, PD; Simon, JA; Valter, I; Zerbini, CAF; Libanati, C; Chines, A Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
Osteoporos Int. 2019; 30(9): 1855-1864. Doi: 10.1007/s00198-019-05020-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Dimai, HP; Ljuhar, R; Ljuhar, D; Norman, B; Nehrer, S; Kurth, A; Fahrleitner-Pammer, A Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial.
Skeletal Radiol. 2019; 48(7):1023-1032 Doi: 10.1007/s00256-018-3118-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Minisola, S; Marin, F; Kendler, DL; Geusens, P; Zerbini, CAF; Russo, LA; Casado, E; Fahrleitner-Pammer, A; Stepan, JJ; Lespessailles, E; Moericke, R; Bagur, A; Lakatos, P; López-Romero, P; Body, JJ Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Arch Osteoporos. 2019; 14(1):10-10 Doi: 10.1007/s11657-019-0561-x
Web of Science PubMed FullText FullText_MUG

** Shboul, M; Roschger, P; Ganger, R; Paschalis, L; Rokidi, S; Zandieh, S; Behunova, J; Muschitz, C; Fahrleitner-Pammer, A; Ng, AYJ; Tohari, S; Venkatesh, B; Bonnard, C; Reversade, B; Klaushofer, K; Al Kaissi, A Bone matrix hypermineralization associated with low bone turnover in a case of Nasu-Hakola disease.
Bone. 2019; 123:48-55 Doi: 10.1016/j.bone.2018.10.008
Web of Science PubMed FullText FullText_MUG

** Steiner, B; Dimai, HP; Steiner, H; Cirar, S; Fahrleitner-Pammer, A Prescreening for Osteoporosis With Quantitative Ultrasound in Postmenopausal White Women.
J Ultrasound Med. 2019; 38(6):1553-1559 Doi: 10.1002/jum.14844 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bencic, D; Schmid, J; Fuchsjager, M; Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Pieber, T; Kolesnik, E; Zirlik, A; Fruhwald, F; von Lewinski, D; Ablasser, K; Verheyen, N; Tomaschitz, A; Scherr, D Association between plasma sodium and bone disease in patients with chronic heart failure: a prospective cohort study
J BONE MINER RES. 2019; 34: 357-357.-Annual Meeting of the American-Society-for-Bone-and Mineral Research; SEP 20-23, 2019; Orlando, FL. [Poster]
Web of Science

** Dimai, HP; Paixao, T; Bertalan, Z; Ljuhar, R; Goetz, C; Ljuhar, D; Nehrer, S; Fahrleitner-Pammer, A Artificial Intelligence (AI) Can Detect Bone Marrow Lesions (BMLs) on Plain Radiographs
J BONE MINER RES. 2019; 34: 199-199.-Annual Meeting of the American-Society-for-Bone-and Mineral Research; SEP 20-23, 2019; Orlando, FL. [Poster]
Web of Science

** Dimai, HP; Paixao, T; Bertalan, Z; Ljuhar, R; Goetz, C; Ljuhar, D; Nehrer, S; Fahrleitner-Pammer, A; Kurth, A DETECTING BONE MARROW LESIONS ON PLAIN RADIOGRAPHS USING ARTIFICIAL INTELLIGENCE (AI): DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI) STUDY
OSTEOPOROSIS INT. 2019; 30: S488-S488.-World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO); APR 04-07, 2019; Paris, FRANCE. [Oral Communication]
Web of Science

** Geusens, P; Kendler, D; Fahrleitner-Pammer, A; Lopez-Romero, P; Marin, F THE DISTRIBUTION OF PREVALENT AND INCIDENT VERTEBRAL FRACTURES IN THE TERIPARATIDE VERSUS RISEDRONATE "VERO" CLINICAL TRIAL
ANN RHEUM DIS. 2019; 78: 929-930.-Annual European Congress of Rheumatology (EULAR); JUN 12-15, 2019; Madrid, SPAIN. Doi: 10.1136/annrheumdis-2019-eular.808 [Oral Communication] [OPEN ACCESS]
Web of Science FullText FullText_MUG

** Malle, O; Bergthaler, M; Muller, C; Krisper, P; Dimai, HP; Kirsch, A; Rosenkranz, A; Pieber, T; Obermayer-Pietsch, B; Fahrleitner-Pammer, A USEFULNESS OF TRABECULAR BONE SCORE IN DIALYSIS PATIENTS
OSTEOPOROSIS INT. 2019; 30: S535-S536.-World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO); APR 04-07, 2019; Paris, FRANCE. [Poster]
Web of Science

2018

Full paper/article (Journal)

** Dempster, DW; Brown, JP; Fahrleitner-Pammer, A; Kendler, D; Rizzo, S; Valter, I; Wagman, RB; Yin, X; Yue, SV; Boivin, G Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.
J Clin Endocrinol Metab. 2018; 103(7):2498-2509 Doi: 10.1210/jc.2017-02669 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Fahrleitner-Pammer, A; Bergthaler, M; Dimai, HP Transplantation Bone Disease Osteopathy following Solid Organ Transplantation (SOT)
OSTEOLOGIE. 2018; 27(1): 24-28. Doi: 10.1055/s-0038-1636975
Web of Science FullText FullText_MUG

** Feichtinger, X; Muschitz, C; Heimel, P; Baierl, A; Fahrleitner-Pammer, A; Redl, H; Resch, H; Geiger, E; Skalicky, S; Dormann, R; Plachel, F; Pietschmann, P; Grillari, J; Hackl, M; Kocijan, R Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry.
SCI REP-UK. 2018; 8(1): 4867-4867. Doi: 10.1038/s41598-018-22844-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Geusens, P; Marin, F; Kendler, DL; Russo, LA; Zerbini, CA; Minisola, S; Body, JJ; Lespessailles, E; Greenspan, SL; Bagur, A; Stepan, JJ; Lakatos, P; Casado, E; Moericke, R; López-Romero, P; Fahrleitner-Pammer, A Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.
J Bone Miner Res. 2018; 33(5):783-794 Doi: 10.1002/jbmr.3384 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Kendler, DL; Marin, F; Zerbini, CAF; Russo, LA; Greenspan, SL; Zikan, V; Bagur, A; Malouf-Sierra, J; Lakatos, P; Fahrleitner-Pammer, A; Lespessailles, E; Minisola, S; Body, JJ; Geusens, P; Möricke, R; López-Romero, P Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet. 2018; 391(10117):230-240 Doi: 10.1016/S0140-6736(17)32137-2
Web of Science PubMed FullText FullText_MUG

** Paschalis, EP; Krege, JH; Gamsjaeger, S; Eriksen, EF; Burr, DB; Disch, DP; Stepan, JJ; Fahrleitner-Pammer, A; Klaushofer, K; Marin, F; Pavo, I Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray-Based Bone Assessment Techniques.
J Bone Miner Res. 2018; 33(12):2230-2235 Doi: 10.1002/jbmr.3565 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Editorial

** Verheyen, N; Grübler, MR; Catena, C; Fahrleitner-Pammer, A; van Ballegooijen, AJ The Bone-Cardiovascular Axis: Mechanisms and Clinical Relevance.
Int J Endocrinol. 2018; 2018(5):9689106-9689106 Doi: 10.1155/2018/9689106 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bertalan, Z; Ljuhar, R; Nehrer, S; Ljuhar, D; Fahrleitner-Pammer, A; Dimai, HP COMBINED FRACTAL- AND ENTROPY-BASED ANALYSIS OF BONE TEXTURE PREDICTS INCIDENT OSTEOARTHRITIS OF THE KNEE: DATA FROM THE MULTICENTER OSTEOARTHRITIS STUDY (MOST)
OSTEOPOROSIS INT. 2018; 29: S245-S245.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 19-22, 2018; Krakow, POLAND. [Oral Communication]
Web of Science

** Bertalan, Z; Ljuhar, R; Norman, B; Ljuhar, D; Fahrleitner-Pammer, A; Dimai, HP; Nehrer, S COMBINING FRACTAL- AND ENTROPY-BASED BONE TEXTURE ANALYSIS FOR THE PREDICTION OF OSTEOARTHRITIS: DATA FROM THE MULTICENTER OSTEOARTHRITIS STUDY (MOST)
OSTEOARTHR CARTILAGE. 2018; 26: S49-S49.-OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis; APR 26-29, 2018; Liverpool, ENGLAND. Doi: 10.1016/j.joca.2018.02.112 [Oral Communication]
Web of Science FullText FullText_MUG

** Body, JJ; Marin, F; Geusens, P; Zerbini, C; Fahrleitner-Pammer, A; Moericke, R; Casado, E; Stepan, J; Minisola, S; Lespessailles, E; Lopez-Romero, P; Kendler, D Efficacy of Teriparatide Compared With Risedronate on FRAX (R)-defined Major Osteoporotic Fractures: A Post-hoc Analysis of the VERO Clinical Trial
J BONE MINER RES. 2018; 33: 113-113.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 28-OCT 01, 2018; Montreal, CANADA. [Oral Communication]
Web of Science

** Hadji, P; Marin, F; Kendler, D; Geusens, P; Russo, L; Malouf, J; Lakatos, P; Minisola, S; Lopez-Romero, P; Fahrleitner-Pammer, A Patient Characteristics and Fracture Outcomes in Patients Previously Treated With Bisphosphonates or Treatment-naive in the Teriparatide versus Risedronate VERO Clinical Trial
J BONE MINER RES. 2018; 33: 286-286.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 28-OCT 01, 2018; Montreal, CANADA. [Poster]
Web of Science

** Ljuhar, R; Bertalan, Z; Nehrer, S; Norman, B; Dimai, HP; Fahrleitner-Pammer, A; Ljuhar, D COMBINING FRACTAL- AND ENTROPY-BASED BONE TEXTURE ANALYSIS FOR THE PREDICTION OF OSTEOARTHRITIS: DATA FROM THE MULTICENTER OSTEOARTHRITIS STUDY (MOST)
ANN RHEUM DIS. 2018; 77: 787-787.-Congress of the European-League-Against-Rheumatism (EULAR); JUN 13-16, 2018; Amsterdam, NETHERLANDS. Doi: 10.1136/annrheumdis-2018-eular.1118 [Oral Communication]
Web of Science FullText FullText_MUG

** Malle, O; Bergthaler, M; Müller, C; Krisper, P; Dimai, HP; Kirsch, A; Rosenkranz, A; Pieber, T; Obermayer-Pietsch, O; Fahrleitner-Pammer, A Usefulness of the Trabecular Bone Score in dialysis patients
J BONE MINER RES. 2018; 33: 101-101.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 28-OCT 01, 2018; Montreal, CANADA. [Poster]
Web of Science

** Malle, O; Borgstroem, F; Svedbom, A; Fahrleitner-Pammer, A; Dimai, SV; Dimai, HP Treatment gap after fracture in osteoporosis patients: results of the austrian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
OSTEOPOROSIS INT. 2018; 29: S292-S292.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 19-22, 2018; Krakow, POLAND. [Poster]
Web of Science

** Malle, O; Borgstroem, F; Svedbom, A; Fahrleitner-Pammer, A; Dimai, SV; Dimai, HP Treatment gap after fracture in osteoporosis patients: results of the austrian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
J BONE MINER RES. 2018; 33: 276-276.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 28-OCT 01, 2018; Montreal, CANADA. [Poster]
Web of Science

** Minisola, S; Marin, F; Kendler, D; Geusens, P; Zerbini, C; Russo, L; Greenspan, S; Casado, E; Fahrleitner-Pammer, A; Stepan, J; Lespessailles, E; Moericke, R; Bagur, A; Lakatos, P; Lopez-Romero, P; Body, JJ VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL
OSTEOPOROSIS INT. 2018; 29: S259-S260.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 19-22, 2018; Krakow, POLAND. [Oral Communication]
Web of Science

** Ulm, S; Fahrleitner-Pammer, A; Pieber, T; Dobnig, H; Sourij, H; Amrein, K Quality of Life and Health Competence in Patients with Diabetes mellitus and other endocrine Diseases
WIEN KLIN WOCHENSCHR. 2018; 130: 360-360. [Poster]
Web of Science

2017

Full paper/article (Journal)

** Bone, HG; Wagman, RB; Brandi, ML; Brown, JP; Chapurlat, R; Cummings, SR; Czerwiński, E; Fahrleitner-Pammer, A; Kendler, DL; Lippuner, K; Reginster, JY; Roux, C; Malouf, J; Bradley, MN; Daizadeh, NS; Wang, A; Dakin, P; Pannacciulli, N; Dempster, DW; Papapoulos, S 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Lancet Diabetes Endocrinol. 2017; 5(7):513-523 Doi: 10.1016/S2213-8587(17)30138-9
Web of Science PubMed FullText FullText_MUG

** Fahrleitner-Pammer, A; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Toffis, C; Frieling, I; Geusens, P; Makras, P; Boschitsch, E; Callens, J; Anastasilakis, AD; Niedhart, C; Resch, H; Kalouche-Khalil, L; Hadji, P Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.
Arch Osteoporos. 2017; 12(1):58-58 Doi: 10.1007/s11657-017-0351-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Frauscher, B; Artinger, K; Kirsch, AH; Aringer, I; Moschovaki-Filippidou, F; Kétszeri, M; Schabhüttl, C; Rainer, PP; Schmidt, A; Stojakovic, T; Fahrleitner-Pammer, A; Rosenkranz, AR; Eller, P; Eller, K A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder.
Int J Endocrinol. 2017; 2017(3):1659071-1659071 Doi: 10.1155/2017/1659071 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Paschalis, EP; Gamsjaeger, S; Hassler, N; Fahrleitner-Pammer, A; Dobnig, H; Stepan, JJ; Pavo, I; Eriksen, EF; Klaushofer, K Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality.
Bone. 2017; 95(2):41-46 Doi: 10.1016/j.bone.2016.11.002
Web of Science PubMed FullText FullText_MUG

** Schwetz, V; Schnedl, C; Urbanic-Purkart, T; Trummer, C; Dimai, HP; Fahrleitner-Pammer, A; Putz-Bankuti, C; Christopher, KB; Obermayer-Pietsch, B; Pieber, TR; Dobnig, H; Amrein, K Effect of vitamin D3 on bone turnover markers in critical illness: post hoc analysis from the VITdAL-ICU study.
Osteoporos Int. 2017; 28(12):3347-3354 Doi: 10.1007/s00198-017-4190-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Verheyen, N; Fahrleitner-Pammer, A; Belyavskiy, E; Gruebler, MR; Dimai, HP; Amrein, K; Ablasser, K; Martensen, J; Catena, C; Pieske-Kraigher, E; Colantonio, C; Voelkl, J; Lang, F; Alesutan, I; Meinitzer, A; März, W; Brussee, H; Pieske, B; Pilz, S; Tomaschitz, A Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.
PLoS One. 2017; 12(4):e0173799-e0173799 Doi: 10.1371/journal.pone.0173799 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Verheyen, N; Grübler, MR; Meinitzer, A; Trummer, C; Schwetz, V; Amrein, K; Dimai, HP; März, W; Catena, C; von Lewinski, D; Voelkl, J; Alesutan, I; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.
Bone. 2017; 105(5):212-217 Doi: 10.1016/j.bone.2017.08.030
Web of Science PubMed FullText FullText_MUG

** Verheyen, N; Meinitzer, A; Grübler, MR; Ablasser, K; Kolesnik, E; Fahrleitner-Pammer, A; Belyavskiy, E; Trummer, C; Schwetz, V; Pieske-Kraigher, E; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; Brussee, H; Lewinski, DV; März, W; Pieske, B; Pilz, S; Tomaschitz, A Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
Clin Chem Lab Med. 2017; 55(7):1034-1042 Doi: 10.1515/cclm-2016-1159
Web of Science PubMed FullText FullText_MUG

** Wetzel, J; Pilz, S; Grübler, MR; Fahrleitner-Pammer, A; Dimai, HP; von Lewinski, D; Kolesnik, E; Perl, S; Trummer, C; Schwetz, V; Meinitzer, A; Belyavskiy, E; Völkl, J; Catena, C; Brandenburg, V; März, W; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, ND Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.
J Clin Hypertens (Greenwich). 2017; 19(11):1173-1180 Doi: 10.1111/jch.13064 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Case Report

** Fahrleitner-Pammer, A; Wagner, D; Krisper, P; Amrein, K; Dimai, H Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
Osteoporos Int. 2017; 28(3):1149-1152 Doi: 10.1007/s00198-016-3858-2 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bertalan, Z; Ljuhar, R; Nehrer, S; Ljuhar, D; Fahrleitner-Pammer, A; Dimai, HP Combining fractal- and entropy-based bone texture analysis for the prediction of Osteoarthritis: data from the Multicenter Osteoarthritis study (MOST).
J BONE MINER RES. 2017; 32: S81-S82. [Poster]
Web of Science FullText

** Dempster, DW; Daizadeh, N; Fahrleitner-Pammer, A; Jensen, JEB; Kendler, D; Valter, I; Wagman, RB; Yue, S; Brown, JP EFFECT OF 10 YEARS OF DENOSUMAB TREATMENT ON BONE HISTOLOGY AND HISTOMORPHOMETRY IN THE FREEDOM EXTENSION STUDY
OSTEOPOROSIS INT. .. 2017; 28: S63-S64.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; MAR 23-26, 2017; Florence, ITALY. [Poster]
Web of Science

** Dimai, HP; Krisper, P; Wagner, D; Fahrleitner-Pammer, A TERIPARATIDE TREATMENT IN A HEART TRANSPLANT PATIENT WITH CHRONIC KIDNEY DISEASE AND LOW-TURNOVER BONE DISEASE: A CASE REPORT
OSTEOPOROSIS INT. 2017; 28: S405-S406.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; MAR 23-26, 2017; Florence, ITALY. [Poster]
Web of Science

** Dimai, HP; Ljuhar, R; Ljuhar, D; Norman, B; Haftner, T; Nehrer, S; Fahrleitner-Pammer, A Fractal-based Assessment of Bone-antiresorptive Treatment Effects at the Lumbar Spine Using Conventional Radiographs; Results from a Pilot Study in a Sub-cohort of Postmenopausal Women who Participated in the FREEDOM Pivotal Trial and its Extension Phase
J BONE MINER RES. 2017; 32: S356-S356. [Poster]
Web of Science FullText

** Geusens, P; Marin, F; Kendler, DL; Russo, L; Zerbini, CAF; Greenspan, S; Minisola, S; Bagur, A; Lakatos, P; Casado, E; Fahrleitner-Pammer, A; Stepan, J; Lespessailles, E; Moericke, R; Body, JJ; Lopez-Romero, P Teriparatide Compared with Risedronate and the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.
J BONE MINER RES. 2017; 32: S22-S22. [Oral Communication]
Web of Science FullText

** Kendler, DL; Zerbini, C; Russo, L; Greenspan, S; Zikan, V; Bagur, A; Malouf, J; Lakatos, P; Fahrleitner-Pammer, A; Lespessailles, E; Minisola, S; Body, JJ; Geusens, P; Moericke, R; Lopez-Romero, P; Marin, F EFFECTS OF 24 MONTHS TREATMENT OF TERIPARATIDE COMPARED WITH RISEDRONATE ON NEW FRACTURES IN POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS: A RANDOMIZED, DOUBLE-DUMMY, CLINICAL TRIAL
OSTEOPOROSIS INT. .. 2017; 28: S69-S70.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; MAR 23-26, 2017; Florence, ITALY. [Poster]
Web of Science

** Ljuhar, R; Dimai, HP; Ljuhar, D; Hladuvka, J; Mai, MBT; Canhao, H; Branco, J; Rodrigues, AM; Gouveia, N; Fahrleitner-Pammer, A; Nehrer, S A NOVEL COMBINATION OF BONE MICRO-ARCHITECTURE DESCRIPTORS FOR THE IDENTIFICATION OF OSTEOARTHRITIS
RHEUMATOLOGY. 2017; 56: 163-163.-Rheumatology Conference; APR 25-27, 2017; Birmingham, ENGLAND. [Oral Communication]
Web of Science

** Ljuhar, R; Haftner, T; Bertalan, Z; Ljuhar, D; Fahrleitner-Pammer, A; Dimai, HP; Nehrer, S A NOVEL METHOD FOR IDENTIFYING RADIOGRAPHIC BASELINE RISK OF OSTEOARTHRITIS USING AN ANISOTROPY-BASED TEXTURE ANALYSIS ALGORITHM: DATA FROM THE OSTEOARTHRITIS INITIATIVE
ANN RHEUM DIS. 2017; 76: 1423-1423.-Annual European Congress of Rheumatology; JUN 14-17, 2017; Madrid, SPAIN. Doi: 10.1136/annrheumdis-2017-eular.5860 [Poster]
Web of Science FullText FullText_MUG

** Ljuhar, R; Haftner, T; Ljuhar, D; Norman, B; Fahrleitner-Pammer, A; Dimai, HP; Hladuvka, J; Nehrer, S A NOVEL METHOD FOR IDENTIFYING RADIOGRAPHIC BASELINE RISK OF OSTEOARTHRITIS USING AN ANISOTROPY-BASED TEXTURE ANALYSIS ALGORITHM: DATA FROM THE OSTEOARTHRITIS INITIATIVE
OSTEOARTHR CARTILAGE. .. 2017; 25: S263-S263.-World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis; APR 27-30, 2017; Las Vegas, NV. Doi: 10.1016/j.joca.2017.02.443 [Poster]
Web of Science FullText FullText_MUG

** Paschalis, E; Krege, J; Gamsjaeger, S; Eriksen, E; Burr, D; Disch, D; Stepan, J; Fahrleitner-Pammer, A; Klaushofer, K; Pavo, I DEXA areal BMD Measurement Underestimates the Bone Forming Effects of Teriparatide.
J BONE MINER RES. 2017; 32: S272-S272. [Poster]
Web of Science FullText

** Zerbini, CAF; Geusens, P; Lespessailles, E; Body, JJ; Casado, E; Stepan, J; Kendler, DL; Russo, L; Greenspan, SL; Minisola, S; Bagur, A; Lakatos, P; Fahrleitner-Pammer, A; Moricke, R; Lopez-Romero, P; Marin, F Teriparatide Compared with Risedronate and the Risk of Clinical Vertebral Fractures: 2-Year Results of a Randomized, Double-Dummy Clinical Trial
ARTHRITIS RHEUMATOL. .. 2017; 69: [Poster]
Web of Science

2016

Full paper/article (Journal)

** Amrein, K; Dimai, HP; Dobnig, H; Fahrleitner-Pammer, A Plasmapheresis and Osteoporosis: The Absence of Evidence Is Not the Evidence of Absence
J MINERAL. 2016; 23(2): 44-47. [OPEN ACCESS]
Web of Science

** Fahrleitner-Pammer, A; Burr, D; Dobnig, H; Stepan, JJ; Petto, H; Li, J; Krege, JH; Pavo, I Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatment.
Bone. 2016; 89(6):16-24 Doi: 10.1016/j.bone.2016.05.004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, B; Richtig, G; Scharnagl, H; Meinitzer, A; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S Effects of vitamin D supplementation on glycated haemoglobin and fasting glucose levels in hypertensive patients: a randomized controlled trial.
Diabetes Obes Metab. 2016; 18(10):1006-12 Doi: 10.1111/dom.12709
Web of Science PubMed FullText FullText_MUG

** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, BW; Richtig, G; Scharnagl, H; Meinitzer, A; Pieske, B; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.
J Clin Hypertens (Greenwich). 2016; 18(7):608-13 Doi: 10.1111/jch.12825 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Grübler, MR; Kienreich, K; Gaksch, M; Verheyen, N; Hartaigh, BÓ; Fahrleitner-Pammer, A; März, W; Schmid, J; Oberreither, EM; Wetzel, J; Catena, C; Sechi, LA; Pieske, B; Tomaschitz, A; Pilz, S Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients.
Medicine (Baltimore). 2016; 95(8):e2794 Doi: 10.1097/MD.0000000000002794 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Kocijan, R; Muschitz, C; Geiger, E; Skalicky, S; Baierl, A; Dormann, R; Plachel, F; Feichtinger, X; Heimel, P; Fahrleitner-Pammer, A; Grillari, J; Redl, H; Resch, H; Hackl, M Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
J Clin Endocrinol Metab. 2016; 101(11):4125-4134 Doi: 10.1210/jc.2016-2365 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Tomaschitz, A; Rus-Machan, J; Dimai, HP; Seiwald, G; Brussee, H; Weinrauch, V; Verheyen, N; Fahrleitner-Pammer, A; Pilz, S The Bone-Cardiovascular Axis: A Systematic Review of Prospective Studies
J MINERAL. 2016; 23(3): 86-93. [OPEN ACCESS]
Web of Science

** Tomaschitz, A; Verheyen, N; Meinitzer, A; Pieske, B; Belyavskiy, E; Brussee, H; Haas, J; März, W; Pieske-Kraigher, E; Verheyen, S; Ofner-Ziegenfuss, L; Hartaigh, BÓ; Schwetz, V; Aberer, F; Grübler, M; Lang, F; Alesutan, I; Voelkl, J; Gaksch, M; Horina, JH; Dimai, HP; Rus-Machan, J; Stiegler, C; Ritz, E; Fahrleitner-Pammer, A; Pilz, S Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
J Hypertens. 2016; 34(7):1347-56 Doi: 10.1097/HJH.0000000000000927
Web of Science PubMed FullText FullText_MUG

** Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86 Doi: 10.1097/HJH.0000000000001004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Verheyen, ND; Kienreich, K; Gaksch, M; van, Ballegooijen, AJ; Grübler, MR; Hartaigh, BÓ; Schmid, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Colantonio, C; Belyavskiy, E; Treiber, G; Catena, C; Brussee, H; Pieske, B; März, W; Tomaschitz, A; Pilz, S Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2016; 18(6):543-50 Doi: 10.1111/jch.12710 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551 Doi: 10.1038/srep33551 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bone, H; Brandi, ML; Brown, J; Chapurlat, R; Cummings, S; Czerwinski, E; Fahrleitner-Pamer, A; Kendler, D; Lippinur, K; Reginster, JY; Vittinghoff, E; Daizadeh, N; Wang, A; Dakin, P; Wagman, R; Papapoulos, S Ten Years of Denosumab Treatment in Postmenopausal Women With Osteoporosis: Results from the FREEDOM Extension Trial
J RHEUMATOL. 2016; 43(6):1209-1209.-Canadian-Rheumatology-Association Meeting; FEB 17-20, 2016; Alberta, CANADA. [Oral Communication]
Web of Science

** Bone, HG; Brandi, ML; Brown, JP; Chapurlat, R; Cummings, SR; Czerwinski, E; Fahrleitner-Pammer, A; Kendler, DL; Lippuner, K; Reginster, JY; Vittinghoff, E; Daizadeh, NS; Wang, A; Dakin, P; Wagman, RB; Papapoulos, SE TEN YEARS OF DENOSUMAB (DMAB) TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FREEDOM EXTENSION TRIAL
OSTEOPOROSIS INT. 2016; 27: S135-S136.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 14-17, 2016; Malaga, SPAIN. [Oral Communication]
Web of Science

** Ljuhar, R; Norman, B; Ljuhar, D; Haftner, T; Hladuvka, J; Canhao, H; Branco, J; Rodrigues, A; Gouveia, N; Nehrer, S; Fahrleitner-Pammer, A; Dimai, HP A NOVEL METHOD FOR THE ASSESSMENT OF KNEE JOINT SPACE WIDTH AND SUBCHONDRAL BONE MICRO ARCHITECTURE
OSTEOARTHR CARTILAGE. 2016; 24: S379-S379. Doi: 10.1016/j.joca.2016.01.677 [Oral Communication]
Web of Science FullText FullText_MUG

** Ljuhar, R; Norman, B; Ljuhar, D; Haftner, T; Hladuvka, J; Mai, PBT; Canhao, H; Branco, J; Rodrigues, AM; Gouveia, N; Nehrer, S; Fahrleitner-Pammer, A; Dimai, HP A CLINICAL STUDY TO EXAMINE THRESHOLDS OF JOINT SPACE WIDTH AND JOINT SPACE AREA FOR IDENTIFICATION OF KNEE OSTEOARTHRITIS
OSTEOPOROSIS INT. 2016; 27: S488-S489.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 14-17, 2016; Malaga, SPAIN. [Oral Communication]
Web of Science

** Ljuhar, R; Norman, B; Ljuhar, D; Haftner, T; Hladuvka, J; Mai, PBT; Canhao, H; Branco, J; Rodrigues, AM; Gouveia, N; Nehrer, S; Fahrleitner-Pammer, A; Dimai, HP A NOVEL FEATURE SELECTION ALGORITHM BASED ON BONE MICROARCHITECTURE ANALYSIS TO IDENTIFY OSTEOARTHRITIS
OSTEOPOROSIS INT. 2016; 27: S426-S427.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 14-17, 2016; Malaga, SPAIN. [Oral Communication]
Web of Science

** Muschitz, CM; Kocijan, R; Haschka, J; Pahr, DP; Kaider, AK; Hans, DH; Fahrleitner-Pammer, A; Resch, HR TBS REFLECTS TRABECULAR MICROARCHITECTURE IN PREMENOPAUSAL WOMEN AND SIMILARLY AGED MEN WITH LOW TRAUMATIC FRACTURES
OSTEOPOROSIS INT. .. 2016; 27: S80-S81.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 14-17, 2016; Malaga, SPAIN. [Poster]
Web of Science

** Verheyen, N; Grubler, M; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A; Marz, W Plasma parathyroid hormone is independently associated with atrial fibrillation - Insights from the LURIC study
WIEN KLIN WOCHENSCHR. 2016; 128: S307-S308. [Poster]
Web of Science

** Verheyen, N; Meinitzer, A; Ablasser, K; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A Serum kynurenine, quinolinic acid and cardiac stiffness parameters: the eplerenone in primary hyperparathyroidism study
WIEN KLIN WOCHENSCHR. 2016; 128: S308-S308. [Poster]
Web of Science

** Wetzel, J; Pilz, S; Gruebler, M; Fahrleitner-Pammer, A; Dimai, HP; Von Lewinski, D; Kolesnik, E; Perl, S; Weinrauch, V; Maerz, W; Belyavskiy, E; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, N Parathyroid hormone is independently associated with systolic blood pressure, pulse wave velocity and left ventricular mass index in patients with primary hyperparathyroidism
EUR HEART J. 2016; 37: 417-417.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Poster]
Web of Science

2015

Full paper/article (Journal)

** Hadji, P; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Zhang, E; Frieling, I; Geusens, P; Makras, P; Resch, H; Möller, G; Kalouche-Khalil, L; Fahrleitner-Pammer, A Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Osteoporos Int. 2015; 26(10):2479-2489 Doi: 10.1007/s00198-015-3164-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Muschitz, C; Kocijan, R; Haschka, J; Pahr, D; Kaider, A; Pietschmann, P; Hans, D; Muschitz, GK; Fahrleitner-Pammer, A; Resch, H TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures.
Bone. 2015; 79(1):259-266 Doi: 10.1016/j.bone.2015.06.007
Web of Science PubMed FullText FullText_MUG

** Pilz, S; Gaksch, M; Kienreich, K; Grübler, M; Verheyen, N; Fahrleitner-Pammer, A; Treiber, G; Drechsler, C; Ó, Hartaigh, B; Obermayer-Pietsch, B; Schwetz, V; Aberer, F; Mader, J; Scharnagl, H; Meinitzer, A; Lerchbaum, E; Dekker, JM; Zittermann, A; März, W; Tomaschitz, A Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
Hypertension. 2015; 65(6):1195-201 Doi: 10.1161/HYPERTENSIONAHA.115.05319 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Tomaschitz, A; Piecha, G; Ritz, E; Meinitzer, A; Haas, J; Pieske, B; Wiecek, A; Rus-Machan, J; Toplak, H; März, W; Verheyen, N; Gaksch, M; Amrein, K; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Pilz, S Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
Clin Exp Hypertens. 2015; 37(2):108-15 Doi: 10.3109/10641963.2014.913604
Web of Science PubMed FullText FullText_MUG

** Tomaschitz, A; Pilz, S; Rus-Machan, J; Meinitzer, A; Brandenburg, VM; Scharnagl, H; Kapl, M; Grammer, T; Ritz, E; Horina, JH; Kleber, ME; Pieske, B; Kraigher-Krainer, E; Hartaigh, BÓ; Toplak, H; van Ballegooijen, AJ; Amrein, K; Fahrleitner-Pammer, A; März, W Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk.
Int J Cardiol. 2015; 184(9):710-716 Doi: 10.1016/j.ijcard.2015.03.062
Web of Science PubMed FullText FullText_MUG

** Tomaschitz, A; Verheyen, N; Gaksch, M; Meinitzer, A; Pieske, B; Kraigher-Krainer, E; Colantonio, C; März, W; Schmidt, A; Belyavskiy, E; Rus-Machan, J; van, Ballegooijen, AJ; Stiegler, C; Amrein, K; Ritz, E; Fahrleitner-Pammer, A; Pilz, S Homoarginine in patients with primary hyperparathyroidism.
Am J Med Sci. 2015; 349(4):306-11 Doi: 10.1097/MAJ.0000000000000419
Web of Science PubMed FullText FullText_MUG

Review

** Schnedl, C; Fahrleitner-Pammer, A; Pietschmann, P; Amrein, K FGF23 in Acute and Chronic Illness.
Dis Markers. 2015; 2015(12):358086-358086 Doi: 10.1155/2015/358086 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bilezkian, JP; Benhamou, CL; Lin, CJF; Brown, JP; Fahrleitner-Pammer, A; Franek, E; Gilchrist, N; Simon, JA; Valter, I; Peters, K Denosumab restores cortical bone loss at the distal radius associated with aging and reduces wrist fracture risk: analyses from the FREEDOM extension cross-over group
AUSTRALAS J AGEING. . 2015; 34: 65-65. [Oral Communication]
Web of Science

** Verheyen, N; Wetzel, J; Martensen, J; Belyavskiy, E; Schmidt, A; Colantonio, C; Catena, C; Gaksch, M; Grübler, MR; Kraigher-Krainer, E; Pieske, B; Meinitzer, A; Rus-Machan, J; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A 9B.05: ASSOCIATION OF PLASMA PARATHYROID HORMONE WITH NIGHTTIME BLOOD PRESSURE IN PRIMARY HYPERPARATHYROIDISM-THE "EPLERENONE IN PRIMARY HYPERPARATHYROIDISM" TRIAL.
J Hypertens. . 2015; 33 Suppl 1(10):e121-e121. Doi: 10.1097/01.hjh.0000467677.24307.ad [Oral Communication]
Web of Science PubMed FullText FullText_MUG

Comment

** Amrein, K; Fahrleitner-Pammer, A; Dimai, HP Bone - a casualty of ICU survival?
Crit Care. 2015; 19(6):253-253 Doi: 10.1186/s13054-015-0977-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2014

Full paper/article (Journal)

** Amrein, K; Dobnig, H; Wagner, D; Piswanger-Sölkner, C; Pieber, TR; Pilz, S; Tomaschitz, A; Dimai, HP; Fahrleitner-Pammer, A Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.
J Am Geriatr Soc. 2014; 62(6):1023-1029 Doi: 10.1111/jgs.12791
Web of Science PubMed FullText FullText_MUG

** Dimai, HP; Svedbom, A; Fahrleitner-Pammer, A; Resch, H; Muschitz, C; Thaler, H; Szivak, M; Amrein, K; Borgström, F Epidemiology of distal forearm fractures in Austria between 1989 and 2010.
Osteoporos Int. 2014; 25(9):2297-2306 Doi: 10.1007/s00198-014-2766-6
Web of Science PubMed FullText FullText_MUG

** Grübler, MR; Kienreich, K; Gaksch, M; Verheyen, N; Fahrleitner-Pammer, A; Schmid, J; Grogorenz, J; Ablasser, K; Pieske, B; Tomaschitz, A; Pilz, S Aldosterone to active renin ratio is associated with nocturnal blood pressure in obese and treated hypertensive patients: the Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2014; 16(4):289-94 Doi: 10.1111/jch.12274 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Kerschan-Schindl, K; Mikosch, P; Obermayer-Pietsch, B; Gasser, RW; Dimai, HP; Fahrleitner-Pammer, A; Dobnig, H; Roschger, P; Preisinger, E; Klaushofer, K; Resch, H; Pietschmann, P Current controversies in clinical management of postmenopausal osteoporosis.
Exp Clin Endocrinol Diabetes. 2014; 122(8):437-444 Doi: 10.1055/s-0034-1374610
Web of Science PubMed FullText FullText_MUG

** Kocijan, R; Muschitz, C; Fahrleitner-Pammer, A; Amrein, K; Pietschmann, P; Haschka, J; Dinu, S; Kapiotis, S; Resch, H Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.
J Clin Endocrinol Metab. 2014; 99(2):E311-E319 Doi: 10.1210/jc.2013-2244 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Ma, YL; Zeng, QQ; Chiang, AY; Burr, D; Li, J; Dobnig, H; Fahrleitner-Pammer, A; Michalská, D; Marin, F; Pavo, I; Stepan, JJ Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment.
Bone. 2014; 59(5):139-147 Doi: 10.1016/j.bone.2013.11.011
Web of Science PubMed FullText FullText_MUG

** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Pavo, I; Haschka, J; Schima, W; Kapiotis, S; Resch, H Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS Study.
J Bone Miner Res. 2014; 29(8):1777-1785 Doi: 10.1002/jbmr.2216 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Roux, C; Hofbauer, LC; Ho, PR; Wark, JD; Zillikens, MC; Fahrleitner-Pammer, A; Hawkins, F; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Bone. 2014; 58(2):48-54 Doi: 10.1016/j.bone.2013.10.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Tomaschitz, A; Meinitzer, A; Pilz, S; Rus-Machan, J; Genser, B; Drechsler, C; Grammer, T; Krane, V; Ritz, E; Kleber, ME; Pieske, B; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Wanner, C; Boehm, BO; März, W Homoarginine, kidney function and cardiovascular mortality risk.
Nephrol Dial Transplant. 2014; 29(3):663-671 Doi: 10.1093/ndt/gft512 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Review

** Tomaschitz, A; Ritz, E; Pieske, B; Rus-Machan, J; Kienreich, K; Verheyen, N; Gaksch, M; Grübler, M; Fahrleitner-Pammer, A; Mrak, P; Toplak, H; Kraigher-Krainer, E; März, W; Pilz, S Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Metabolism. 2014; 63(1):20-31 Doi: 10.1016/j.metabol.2013.08.016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bilezikian, JP; Benhamou, CL; Lin, CJF; Brown, JP; Daizadeh, NS; Ebeling, PR; Fahrleitner-Pammer, A; Franek, E; Gilchrist, N; Miller, PD; Simon, JA; Valter, I; Zerbini, CAF; Libanati, C Denosumab Restores Cortical Bone Loss at the Distal Radius Associated with Aging and Reduces Wrist Fracture Risk. Analyses from the Cross-over Group in the Extension of Denosumab Pivotal Fracture Trial
ARTHRITIS RHEUMATOL. . 2014; 66: S788-S789. [Poster]
Web of Science

** Hadji, P; Papaioannou, NA; Gielen, E; Tepie, MF; Zhang, E; Kalouche-Khalil, L; Fahrleitner-Pammer, A 12-MONTH PERSISTENCE WITH DENOSUMAB (DMAB) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO): INTERIM RESULTS OF A 24-MONTH PROSPECTIVE OBSERVATIONAL STUDY IN GERMANY, AUSTRIA, GREECE AND BELGIUM
OSTEOPOROSIS INT. 2014; 25: S181-S182.-World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 02-05, 2014; Seville, SPAIN. [Oral Communication]
Web of Science

2013

Full paper/article (Journal)

** Dimai, HP; Svedbom, A; Fahrleitner-Pammer, A; Pieber, T; Resch, H; Zwettler, E; Thaler, H; Szivak, M; Amrein, K; Borgström, F Epidemiology of proximal humeral fractures in Austria between 1989 and 2008.
Osteoporos Int. 2013; 24(9):2413-2421 Doi: 10.1007/s00198-013-2339-0
Web of Science PubMed FullText FullText_MUG

** Friedl, C; Hemetsberger, M; Mader, J; Fahrleitner-Pammer, A; Pieber, TR; Rosenkranz, AR Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture.
Wien Klin Wochenschr. 2013; 125(13-14):362-367 Doi: 10.1007/s00508-013-0374-7
Web of Science PubMed FullText FullText_MUG

** Kleber, ME; Seppälä, I; Pilz, S; Hoffmann, MM; Tomaschitz, A; Oksala, N; Raitoharju, E; Lyytikäinen, LP; Mäkelä, KM; Laaksonen, R; Kähönen, M; Raitakari, OT; Huang, J; Kienreich, K; Fahrleitner-Pammer, A; Drechsler, C; Krane, V; Boehm, BO; Koenig, W; Wanner, C; Lehtimäki, T; März, W; Meinitzer, A Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.
Circ Cardiovasc Genet. 2013; 6(5):505-513 Doi: 10.1161/CIRCGENETICS.113.000108 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Ljunggren, Ö; Barrett, A; Stoykov, I; Langdahl, BL; Lems, WF; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Jakob, F; Karras, D; Marin, F Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study.
BMC Musculoskelet Disord. 2013; 14(8):251-251 Doi: 10.1186/1471-2474-14-251 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Lung, S; Resch, H Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density.
J Bone Miner Res. 2013; 28(1):196-205 Doi: 10.1002/jbmr.1716 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Pilz, S; Meinitzer, A; Tomaschitz, A; Kienreich, K; Dobnig, H; Schwarz, M; Wagner, D; Drechsler, C; Piswanger-Sölkner, C; März, W; Fahrleitner-Pammer, A Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients.
Osteoporos Int. 2013; 24(1):377-381 Doi: 10.1007/s00198-012-1950-9
Web of Science PubMed FullText FullText_MUG

** Tomaschitz, A; Pilz, S; Pieske, B; Ritz, E; März, W; Meinitzer, A; Dobnig, H; Amrein, K; Kienreich, K; Verheyen, N; Kraigher-Krainer, E; Drechsler, C; Colantonio, C; Wagner, D; Fahrleitner-Pammer, A Circulating aldosterone and mortality in female nursing home residents.
Exp Gerontol. 2013; 48(3):313-318 Doi: 10.1016/j.exger.2013.01.004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Wagner, D; Bradatsch, A; Kniepeiss, D; Schaffellner, S; Jakoby, E; Muller, H; Pirker, S; Fahrleitner-Pammer, A; Tscheliessnigg, KH; Iberer, F; Incidence of ischemic type biliary lesions after liver transplantation using piggyback technique and retrograde reperfusion.
EUR SURG. 2013; 45(1): 3-7. Doi: 10.1007/s10353-012-0166-8
Web of Science FullText FullText_MUG

** Werkgartner, G; Wagner, D; Manhal, S; Fahrleitner-Pammer, A; Mischinger, HJ; Wagner, M; Grgic, R; Roller, RE; Kniepeiss, D Long-term quality of life of liver transplant recipients beyond 60 years of age.
Age (Dordr). 2013; 35(6):2485-2492 Doi: 10.1007/s11357-013-9527-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Review

** Kerschan-Schindl, K; Haschka, J; Obermayer-Pietsch, B; Gasser, RW; Dimai, HP; Fahrleitner-Pammer, A; Dobnig, H; Roschger, P; Preisinger, E; Klaushofer, K; Resch, H; Pietschmann, P How long should women with postmenopausal osteoporosis be treated with a bisphosphonate?
Horm Metab Res. 2013; 45(9):621-628 Doi: 10.1055/s-0033-1345207
Web of Science PubMed FullText FullText_MUG

** Verheyen, N; Pilz, S; Eller, K; Kienreich, K; Fahrleitner-Pammer, A; Pieske, B; Ritz, E; Tomaschitz, A Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
Expert Opin Pharmacother. 2013; 14(6):793-806 Doi: 10.1517/14656566.2013.777041
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Grubler, M; Kienreich, K; Tomaschitz, A; Verheyen, N; Gaksch, M; Fahrleitner-Pammer, A; Schmid, J; Pieske, B; Pieber, TR; Pilz, S; Aldosterone to renin ratio is associated with 24 hour ambulatory blood pressure in essential hypertensives: the Styrian Hypertension study.
EUR HEART J. 2013; 34: 1051-1051.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

** Grubler, MR; Verheyen, N; Pilz, S; Kienreich, K; Gaksch, M; Schmid, J; Rus-Machan, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Pieske, B; Marz, W; Tomaschitz, A Is Resting Heart Rate Really Associated With Cardiovascular Mortality?
CIRCULATION. 2013; 128(22): [Poster]
Web of Science FullText

** Grubler, MR; Verheyen, N; Tomaschitz, A; Kienreich, K; Gaksch, M; Bersuch, LA; Fahrleitner-Pammer, A; Schmid, J; Marz, W; Pieske, B; Pilz, S Nocturnal Diastolic Blood Pressure is Associated With 24 Hour Urinary Albumin in Essential Hypertensive Patients
CIRCULATION. 2013; 128(22): [Oral Communication]
Web of Science FullText

** Hofbauer, LC; Fahrleitner-Pammer, A; Ho, PR; Hawkins, F; Roux, C; Micaelo, M; Minisola, S; Papaioannou, NA; Stone, M; Wark, J; Zillikens, MC; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP; EFFICACY AND SAFETY OF DENOSUMAB VS. RISEDRONATE IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE: RESULTS FROM A RANDOMIZED OPEN-LABEL STUDY.
OSTEOPOROSIS INT. 2013; 24: S218-S219.-European Congress on Osteoporosis and Osteoarthritis (ESCEO-IOF); APR 17-20, 2013; Rome, ITALY. [Oral Communication]
Web of Science

** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Lung, S; Resch, H; OVERLAPPING AND FOLLOW-U P OF ALENDRONATE TO TERIPARATIDE TREATMENT RESULTS IN MAINTENANCE OF EXCESS BMD GAIN.
OSTEOPOROSIS INT. 2013; 24: S93-S93.-European Congress on Osteoporosis and Osteoarthritis (ESCEO-IOF); APR 17-20, 2013; Rome, ITALY. [Oral Communication]
Web of Science

** Roux, C; Fahrleitner-Pammer, A; Ho, PR; Hawkins, F; Hofbauer, LC; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Wark, J; Zillikens, MC; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY
ANN RHEUM DIS. 2013; 72: 306-306.-ASBMR; Oct 2013; Minneapolis. [Oral Communication]
Web of Science

** Verheyen, N; Grubler, M; Pilz, S; Kienreich, K; Gaksch, M; Schmid, J; Bersuch, LA; Pieske, B; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Boehm, BO; Marz, W; Tomaschitz, A Serum Parathyroid Hormone is Independently Associated With Atrial Fibrillation: Insights From the LURIC Study
CIRCULATION. 2013; 128(22): [Poster]
Web of Science FullText

** Werkgartner, G; Fahrleitner-Pammer, A; Roller-Wirnsberger, R; Kniepeiss, D; Wagner, D LONG TERM QUALITY OF LIFE OF LIVER TRANSPLANT RECIPIENTS BEYOND SIXTY YEARS OF AGE
TRANSPL INT. . 2013; 26: 189-189. [Poster]
Web of Science

2012

Full paper/article (Journal)

** Amrein, K; Amrein, S; Drexler, C; Dimai, HP; Dobnig, H; Pfeifer, K; Tomaschitz, A; Pieber, TR; Fahrleitner-Pammer, A Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
J Clin Endocrinol Metab. 2012; 97(1):148-154 Doi: 10.1210/jc.2011-2152 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Friedl, C; Sampl, E; Prandl, EC; Wagner, D; Piswanger-Soelkner, JC; Rosenkranz, AR; Fahrleitner-Pammer, A Osteoporosis, weight gain and atypical fat accumulations - a typical feature not only for Cushing's, but also Madelung's disease: A case report.
Wien Klin Wochenschr. 2012; 124(5-6):188-192 Doi: 10.1007/s00508-011-0045-5 (- Case Report)
Web of Science PubMed FullText FullText_MUG

** Jakob, F; Oertel, H; Langdahl, B; Ljunggren, O; Barrett, A; Karras, D; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Barker, C; Lems, WF; Marin, F Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study.
Eur J Endocrinol. 2012; 166(1):87-97 Doi: 10.1530/EJE-11-0740 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Karras, D; Stoykov, I; Lems, WF; Langdahl, BL; Ljunggren, ; Barrett, A; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Jakob, F; Marin, F Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-year results from the EFOS study.
J Rheumatol. 2012; 39(3):600-609 Doi: 10.3899/jrheum.110947
Web of Science PubMed FullText FullText_MUG

** Pilz, S; Dobnig, H; Tomaschitz, A; Kienreich, K; Meinitzer, A; Friedl, C; Wagner, D; Piswanger-Sölkner, C; März, W; Fahrleitner-Pammer, A Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents.
J Clin Endocrinol Metab. 2012; 97(4): E653-E657. Doi: 10.1210/jc.2011-3043 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Pilz, S; Kienreich, K; Drechsler, C; Ritz, E; Fahrleitner-Pammer, A; Gaksch, M; Meinitzer, A; März, W; Pieber, TR; Tomaschitz, A Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
J Clin Endocrinol Metab. 2012; 97(1):E75-9 Doi: 10.1210/jc.2011-2183 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Tomaschitz, A; Fahrleitner-Pammer, A; Pieske, B; Verheyen, N; Amrein, K; Ritz, E; Kienreich, K; Horina, JH; Schmidt, A; Kraigher-Krainer, E; Colantonio, C; Meinitzer, A; Pilz, S Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.
BMC Endocr Disord. 2012; 12(12):19-19 Doi: 10.1186/1472-6823-12-19 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Tomaschitz, A; Ritz, E; Pieske, B; Fahrleitner-Pammer, A; Kienreich, K; Horina, JH; Drechsler, C; März, W; Ofner, M; Pieber, TR; Pilz, S Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Cardiovasc Res. 2012; 94(1):10-19 Doi: 10.1093/cvr/cvs092 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Wagner, D; Amrein, K; Dimai, HP; Kniepeiss, D; Tscheliessnigg, KH; Kornprat, P; Dobnig, H; Pieber, T; Fahrleitner-Pammer, A Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Transplantation. 2012; 93(3):331-336 Doi: 10.1097/TP.0b013e31823f7f68 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Wagner, D; Kniepeiss, D; Stiegler, P; Zitta, S; Bradatsch, A; Robatscher, M; Müller, H; Meinitzer, A; Fahrleitner-Pammer, A; Wirnsberger, G; Iberer, F; Tscheliessnigg, K; Reibnegger, G; Rosenkranz, AR The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations.
Transpl Int. 2012; 25(5):527-536 Doi: 10.1111/j.1432-2277.2012.01449.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Walsh, JB; Lems, WF; Karras, D; Langdahl, BL; Ljunggren, O; Fahrleitner-Pammer, A; Barrett, A; Rajzbaum, G; Jakob, F; Marin, F Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).
Calcif Tissue Int. 2012; 90(5):373-383 Doi: 10.1007/s00223-012-9590-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Short report/Letter

** Pilz, S; Meinitzer, A; Tomaschitz, A; Kienreich, K; Fahrleitner-Pammer, A; Drechsler, C; Boehm, BO; März, W Homoarginine deficiency is associated with increased bone turnover.
Osteoporos Int. 2012; 23(11):2731-2732 Doi: 10.1007/s00198-012-1904-2
Web of Science PubMed FullText FullText_MUG

Review

** Muschitz, C; Fahrleitner-Pammer, A; Huber, J; Preisinger, E; Kudlacek, S; Resch, H Update on denosumab in postmenopausal osteoporosis--recent clinical data.
Wien Med Wochenschr. 2012; 162(17-18):374-379 Doi: 10.1007/s10354-012-0116-x
PubMed FullText FullText_MUG

Correspondence

** Pilz, S; Tomaschitz, A; Kienreich, K; Fahrleitner-Pammer, A; März, W Correspondence (letter to the editor): Appeal for Vitamin D Therapy.
Dtsch Arztebl Int. 2012; 109(19): 359; author reply 359-359; author reply 360. Doi: 10.3238/arztebl.2012.0359a [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Kocijan, R; Muschitz, C; Amrein, K; Fahrleitner-Pammer, A; Pietschmann, P; Haschka, J; Dinu, S; Resch, H; Serum sclerostin levels, bone turnover markers and body composition in mild, moderate and severe osteogenesis imperfecta.
BONE. 2012; 51(6):S10-S11.-International Conference on Progress in Bone and Mineral Research / Annual Autumn Conference of the Austrian-Society-for-Bone-and-Mineral-Research including a Symposium on Calcium Sensing Receptor; NOV 29-DEC 01, 2012; Vienna, AUSTRIA. Doi: 10.1016/j.bone.2012.08.029 [Oral Communication]
Web of Science FullText FullText_MUG

** Muschitz, C; Fahrleitner-Pammer, A; Kocijan, R; Bittighofer, C; Trubrich, A; Kuehne, F; Waneck, R; Resch, H; TERIPARATIDE AND ANTIRESORPTIVE COMBINATION TREATMENT SUBSEQUENT TO 9 MONTHS OF TERIPARATIDE MONOTHERAPY.
OSTEOPOROSIS INT. 2012; 23: S106-S107.-IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium; MAR 21-24, 2012; Bordeaux, FRANCE. [Oral Communication]
Web of Science

** Muschitz, C; Haschka, J; Kocijan, R; Bitighofer, C; Trubrich, A; Fahrleitner-Pammer, A; Resch, H; TREATMENT WITH PTH 1-84 IN MALE PATIENTS WITH SEVERE OSTEOPOROSIS - RESULTS FROM A PROSPECTIVE 24 MONTH OPEN-LABEL TRIAL.
OSTEOPOROSIS INT. 2012; 23: S107-S107.-IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium; MAR 21-24, 2012; Bordeaux, FRANCE. [Oral Communication]
Web of Science

** Muschitz, C; Haschka, J; Kocijan, R; Bittighofer, C; Trubrich, A; Fahrleitner-Pammer, A; Resch, H; Treatment with PTH 1-84 in male patients with severe osteoporosis - results from a prospective 24 month open-label trial.
BONE. 2012; 50: S154-S154.-39th Annual Congress of the European-Calcified-Tissue-Society (ECTS); MAY 19-23, 2012; Stockholm, SWEDEN. Doi: 10.1016/j.bone.2012.02.481 [Oral Communication]
Web of Science FullText FullText_MUG

** Muschitz, C; Haschka, J; Kocijan, R; Fahrleitner-Pammer, A; Nirnberger, G; Resch, H TREATMENT WITH PTH 1-84 IN MALE PATIENTS WITH SEVERE OSTEOPOROSIS RESULTS FROM A PROSPECTIVE 24 MONTH OPEN-LABEL TRIAL
OSTEOPOROSIS INT. 2012; 23: 696-696.-IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC); SEP 27-OCT 01, 2012; JORDAN. [Oral Communication]
Web of Science

** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Lung, S; Resch, H; Overlapping and follow-up of alendronate to teriparatide treatment results in maintenance of excess BMD gain.
BONE. 2012; 51(6):S10-S10.-International Conference on Progress in Bone and Mineral Research / Annual Autumn Conference of the Austrian-Society-for-Bone-and-Mineral-Research including a Symposium on Calcium Sensing Receptor; NOV 29-DEC 01, 2012; Vienna, AUSTRIA. Doi: 10.1016/j.bone.2012.08.028 [Keynote lecture]
Web of Science FullText FullText_MUG

** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Pavo, I; Lung, S; Resch, H ANTIRESORPTIVES OVERLAPPING ONGOING TERIPARATIDE TREATMENT RESULT IN ADDITIONAL INCREASES IN BONE MINERAL DENSITY
OSTEOPOROSIS INT. 2012; 23: 695-695.-IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC); SEP 27-OCT 01, 2012; JORDAN. [Oral Communication]
Web of Science

** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Pavo, I; Resch, H OVERLAPPING AND FOLLOW-UP OF ALENDRONATE TO TERIPARATIDE TREATMENT RESULTS IN MAINTENANCE OF EXCESS BMD GAIN
OSTEOPOROSIS INT. . 2012; 23: 697-697.-IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC); SEP 27-OCT 01, 2012; JORDAN. [Oral Communication]
Web of Science

** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Resch, H OVERLAPPING AND FOLLOW-UP OF ALENDRONATE TO TERIPARATIDE TREATMENT RESULTS IN MAINTENANCE OF EXCESS BMD GAIN
OSTEOPOROSIS INT. . 2012; 23: S750-S751.-IOF Regionals - 3rd Asia-Pacific Osteoporosis Meeting; DEC 13-16, 2012; Kuala Lumpur, MALAYSIA. [Poster]
Web of Science

** Muschitz, C; Kocijan, R; Kuehne, F; Haschka, J; Bittighofer, C; Trubrich, A; Fahrleitner-Pammer, A; Resch, H; Teriparatide and antiresorptive combination treatment subsequent to 9 months of teriparatide monotherapy.
BONE. 2012; 50: S41-S41.-39th Annual Congress of the European-Calcified-Tissue-Society (ECTS); MAY 19-23, 2012; Stockholm, SWEDEN. Doi: 10.1016/j.bone.2012.02.107 [Oral Communication]
Web of Science FullText FullText_MUG

** Muschitz, C; Kocijan, R; Kuehne, F; Haschka, J; Bittighofer, C; Trubrich, A; Fahrleitner-Pammer, A; Resch, H; The discriminatory capacity of clinical risk factors and bmd measurements at different skeletal sites for detect-ing patients with vertebral fractures.
BONE. 2012; 50: S147-S147.-39th Annual Congress of the European-Calcified-Tissue-Society (ECTS); MAY 19-23, 2012; Stockholm, SWEDEN. Doi: 10.1016/j.bone.2012.02.457 [Oral Communication]
Web of Science FullText FullText_MUG

** Stepan, JJ; Dobnig, H; Fahrleitner-Pammer, A; Ma, YFL; Zeng, QQ; Wan, XH; Marin, F; Pavo, I; EFFECTS OF TERIPARATIDE ON CORTICAL HISTOMORPHOMETRIC VARIBLES IN PATIENTS RECEIVING LONG-TERM ALENDRONATE THERAPY.
OSTEOPOROSIS INT. 2012; 23: S132-S132.-IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium; MAR 21-24, 2012; Bordeaux, FRANCE. [Oral Communication]
Web of Science

** Wagner, D; Kniepeiss, D; Stiegler, P; Zitta, S; Muller, H; Meinitzer, A; Fahrleitner-Pammer, A; Rosenkranz, AR THE ASSESSMENT OF GFR AFTER ORTHOTOPIC LIVER TRANSPLANTATION USING CYSTATIN C AND CREATININE-BASED EQUATIONS
J HEPATOL. 2012; 56: S96-S96.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)60242-6 [Poster]
Web of Science FullText FullText_MUG

2011

Full paper/article (Journal)

** Amrein, K; Dimai, HP; Dobnig, H; Fahrleitner-Pammer, A Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.
Osteoporos Int. 2011; 22(11):2903-2905 Doi: 10.1007/s00198-010-1441-9 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

** Amrein, K; Langmann, A; Fahrleitner-Pammer, A; Pieber, TR; Zollner-Schwetz, I Women underrepresented on editorial boards of 60 major medical journals.
Gend Med. 2011; 8(6):378-387 Doi: 10.1016/j.genm.2011.10.007
Web of Science PubMed FullText FullText_MUG Google Scholar

** Dimai, HP; Svedbom, A; Fahrleitner-Pammer, A; Pieber, T; Resch, H; Zwettler, E; Chandran, M; Borgström, F Epidemiology of hip fractures in Austria: evidence for a change in the secular trend.
Osteoporos Int. 2011; 22(2): 685-692. Doi: 10.1007/s00198-010-1271-9
Web of Science PubMed FullText FullText_MUG Google Scholar

** Fahrleitner-Pammer, A; Langdahl, BL; Marin, F; Jakob, F; Karras, D; Barrett, A; Ljunggren, O; Walsh, JB; Rajzbaum, G; Barker, C; Lems, WF Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS).
Osteoporos Int. 2011; 22(10): 2709-2719. Doi: 10.1007/s00198-010-1498-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Malliga, DE; Wagner, D; Fahrleitner-Pammer, A The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review.
Wien Med Wochenschr. 2011; 161(23-24):565-570 Doi: 10.1007/s10354-011-0022-7
PubMed FullText FullText_MUG

** Wagner, D; Adunka, C; Kniepeiss, D; Jakoby, E; Schaffellner, S; Kandlbauer, M; Fahrleitner-Pammer, A; Roller, RE; Kornprat, P; Müller, H; Iberer, F; Tscheliessnigg, KH Serum albumin, subjective global assessment, body mass index and the bioimpedance analysis in the assessment of malnutrition in patients up to 15 years after liver transplantation.
Clin Transplant. 2011; 25(4):E396-E400 Doi: 10.1111/j.1399-0012.2011.01442.x
Web of Science PubMed FullText FullText_MUG

Short report/Letter

** Amrein, K; Schilcher, G; Fahrleitner-Pammer, A Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose.
Eur Respir J. 2011; 37(2): 470-471. Doi: 10.1183/09031936.00136910 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Abstract (Journal)

** Amrein, K; Dimai, HP; Dobnig, H; Fahrleitner-Pammer, A POSTOPERATIVE HYPOPARATHYROIDISM, LOW BONE TURNOVER AND INCREASE IN BONE MINERAL DENSITY DESPITE THYROXINE SUPPRESSIVE THERAPY IN A PREMENOPAUSAL WOMAN
OSTEOPOROSIS INT. 2011; 22: 182-183. [Poster]
Web of Science

** Dimai, H; Chandran, M; Svedbom, A; Thaler, H; Amrein, K; Fahrleitner-Pammer, A; Zwettler, E; Borgstrom, F INCIDENCE OF HUMERAL FRACTURES IN AUSTRIA BETWEEN 1989 AND 2008
OSTEOPOROSIS INT. 2011; 22: 306-307.-European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF); MAR 23-26, 2011; Valencia, SPAIN. [Poster]
Web of Science

** Dimai, HP; Svedbom, A; Chandran, M; Amrein, K; Fahrleitner-Pammer, A; Zwettler, E; Borgstrom, F Epidemiology of humeral fractures in Austria between 1989 and 2008
BONE. . 2011; 48: S190-S191.-3rd Joint Meeting of the European Calcified Tissue Society & the International Bone and Mineral Society; MAY 7-11, 2011; Doi: 10.1016/j.bone.2011.03.449 [Poster]
Web of Science FullText FullText_MUG

** Muschitz, C; Haschka, J; Kocijan, R; Trubrich, A; Fahrleitner-Pammer, A; Nirnberger, G; Resch, H Treatment with PTH 1-84 in male patients with severe osteoporosis - Results from a prospective 24 month open-label trial
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A51-A51.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA. [Poster]
Web of Science

** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Bittighofer, C; Trubrich, A; Kuhne, F; Waneck, R; Resch, H Teriparatide and antiresorptive combination treatment subsequent to 9 Months of osteoanabolic monotherapy in female patients with severe osteoporosis and prevalent fragility fractures
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A51-A51.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA. [Poster]
Web of Science

** Wagner, D; Dimai, HP; Amrein, K; Dobnig, H; Kniepeiss, D; Fahrleitner, A COMBINATION THERAPY WITH IBANDRONATE AND CALCITRIOL IS EFFECTIVE IN PATIENTS FOLLOWING LIVER TRANSPLANTATION (LTX): A THREE YEAR PROSPECTIVE CONTROLLED STUDY
TRANSPL INT. . 2011; 24: 345-345.-15th Congress of the ESOT and 22nd Annual Conference of the BSHI; SEP 4-7, 2011; Glasgow, UK. [Poster]
Web of Science

** Wagner, D; Dobnig, H; Tscheliessnigg, K; Prenner, G; Wasler, A; Piswagner-Solkner, C; Kniepeiss, D; Fahrleinter, A TESTOSTERONE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS ON TOP OF BISPHOSPHONATE THERAPY EXERTS MULTIPLE BENEFITS ON BONE MASS, LIBIDO AND SEXUAL ACTIVITY
TRANSPL INT. 2011; 24: 332-332. [Oral Communication]
Web of Science

** Wagner, D; Telsnig, B; Kniepeiss, D; Jakoby, E; Schaffellner, S; Fahrleitner-Pammer, A; Wasler, A; Roller, R; Tscheliessnigg, K THE ROLE OF SERUM ALBUMIN (SA) IN THE PREDICTION OF MALNUTRITION IN PATIENT AT LEAST ONE HEART TRANSPLANTATION (HTX)
TRANSPL INT. 2011; 24: 270-271. [Poster]
Web of Science

2010

Full paper/article (Journal)

** Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR) Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Wien Med Wochenschr. 2010; 160(21-22):586-589 Doi: 10.1007/s10354-010-0840-z
PubMed FullText FullText_MUG

** Pietschmann, P; Azizi-Semrad, U; Pils, K; Fahrleitner-Pammer, A; Resch, H; Dobnig, H Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences.
Wien Klin Wochenschr. 2010; 122(17-18): 532-537. Doi: 10.1007/s00508-010-1428-8
Web of Science PubMed FullText FullText_MUG Google Scholar

** Reid, I; Miller, P; Brown, J; Kendler, D; Fahrleitner-Pammer, A; Valter, I; Maasalu, K; Bolognese, M; Woodson, G; Bone, H; Ding, B; Wagman, R; Martin, JS; Ominsky, M; Dempster, D; on behalf of the Denosumab Phase 3 Bone Histology Study Group Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies.
J Bone Miner Res. 2010; 25(10): 2256-2265. Doi: 10.1002/jbmr.149 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Sampl, E; Wagner, D; Friedl, C; Dobnig, H; Fahrleitner-Pammer, A Vitamin D deficiency following Billroth II surgery - How much vitamin D is enough?: a case report.
Cases J. 2010; 3(1):12-12 Doi: 10.1186/1757-1626-3-12 [OPEN ACCESS]
PubMed FullText FullText_MUG

** Stepan, JJ; Burr, DB; Li, J; Ma, YL; Petto, H; Sipos, A; Dobnig, H; Fahrleitner-Pammer, A; Michalská, D; Pavo, I Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis.
Osteoporos Int. 2010; 21(12): 2027-2036. Doi: 10.1007/s00198-009-1168-7
Web of Science PubMed FullText FullText_MUG Google Scholar

** Tomaschitz, A; Maerz, W; Pilz, S; Ritz, E; Scharnagl, H; Renner, W; Boehm, BO; Fahrleitner-Pammer, A; Weihrauch, G; Dobnig, H Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
J Am Coll Cardiol. 2010; 55(19): 2171-2180. Doi: 10.1016/j.jacc.2010.01.032 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Wagner, D; Fahrleitner-Pammer, A Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?
Wien Med Wochenschr. 2010; 160(17-18): 452-457. Doi: 10.1007/s10354-010-0818-x
PubMed FullText FullText_MUG

** Wagner, D; Iberer, F; Sereinigg, M; Kniepeiss, D; Kornprat, P; Fahrleitner-Pammer, A; Stiegler, P; Tscheliessnigg, K Massive diaphragmatic herniation following orthotopic liver transplantation in an adult.
Liver Transpl. 2010; 16(6):783-785 Doi: 10.1002/lt.22079 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Wagner, D; Kniepeiss, D; Schaffellner, S; Jakoby, E; Mueller, H; Fahrleitner-Pammer, A; Tscheliessnigg, KH; Iberer, F Sirolimus has a potential to influent viral recurrence in HCV positive liver transplant candidates.
Int Immunopharmacol. 2010; 10(8): 990-993. Doi: 10.1016/j.intimp.2010.05.006
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Dobnig, H; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Bohm, B; Fahrleitner-Pammer, A; Marz, W INFLUENCE OF 25-HYDROXYVITAMIN D STATUS ON SERUM PARATHYROID HORMONE LEVELS VARIES WITH KDOQI CLASSIFICATION OF RENAL FUNCTION AND IS INDEPENDENT OF 1,25 DIHYDROXYVITAMIN D CONCENTRATIONS
OSTEOPOROSIS INT. 2010; 21: 11-11. -IOF World Congress on Osteoporosis 10Th European Congress on Clinical an Economic Aspects of Osteoporosis and Osteoarthritis ; 5-8 May ; Florence, Italy. [Oral Communication]
Web of Science FullText

** Fahrleitner-Pammer, A; Ljunggren, O; Langdahl, B; Walsh, B; Barker, C; Lems, W; Karras, D; Rajzbaum, G; Jakob, F; Barrett, A; Marin, F CHANGES IN QUALITY OF LIFE AND BACK PAIN IN WOMEN WITH OSTEOPOROSIS TREATED WITH RHPTH(1-34) (TERIPARATIDE): 36 MONTH RESULTS FROM THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)
OSTEOPOROSIS INT. 2010; 21: 156-157. -IOF World Congress on Osteoporosis tenth European Congress on Clinical and Economic Aspects of Osteoporosis and osteoarthritis; 5-8 may 2010; Florence, Italy. [Poster]
Web of Science FullText

** Fruhwald, FM; Fahrleitner-Pammer, A; Wagner, D; Haas, J; Erdmann, E; Tavazzi, L; Schoppet, M; Cleland, JGF Prognostic impact of serum osteoprotegerin, NT-pro-BNP and big endothelin levels in patients with heart failure and ventricular dysynchrony. Results from the CARE-HF study.
Eur Heart J2010; 31: 1048-1048.-ESC congress 2010; Aug 28 - Sep 1, 2010; Stockholm, Schweden. [Poster]
Web of Science

** Reid, I; Miller, P; Brown, JP; Kendler, D; Fahrleitner-Pammer, A; Valter, I; Maasalu, K; Bolognese, M; Woodson, G; Bone, HG; Ding, B; Wagman, RB; San Martin, J; Ominsky, MS; Dempster, DW EFFECT OF DENOSUMAB TREATMENT ON BONE HISTOLOGY AND HISTOMORPHOMETRY: THE FREEDOM AND STAND STUDIES
OSTEOPOROSIS INT. 2010; 21: 134-134. -11.-IOF World Congress on Osteoporosis 10Th European Congress on Clinical an Economic Aspects of Osteoporosis and Osteoarthritis ; 5-8 May ; Florence, Italy. [Poster]
Web of Science FullText

** Wagner, D; Adunka, C; Kaindlbauer, M; Kniepess, D; Schaffellner, S; Jakoby, E; Iberer, F; Roller-Wirnsberger, R; Fahrleitner-Pammer, A; Tscheliessnigg, KH Comparison of Antrophometric Measurements, Laboratory Parameters and Bio Impedance Analysis in the Assessment of Malnutrition in Patients 5, 10 and 15 Years after Liver Transplantation
LIVER TRANSPLANT. 2010; 16(6):S248-S248.-Meeting of the International Liver Transplantation Society; JUN 10-16; Hongkong, CHINA. [Poster]
Web of Science

** Wagner, D; Dobnig, H; Iberer, F; Prenner, G; Kniepeiss, D; Leb, G; Tscheliessnig, KH; Piswanger, C; Fahrleitner, A Combination Therapy with Ibandronate and Calcitrol Is Efffective in Patients Following Liver Transplantation (LTX): A Three Year Prospective Controlled Study
LIVER TRANSPLANT. 2010; 16(6):S248-S248. [Poster]
Web of Science

** Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Schaffellner, S; Tscheliessnigg, K; Pieber, T; Fahrleitner, A Combination Therapy with Ibandronate and Calcitrol Is Efffective in Patients Following Liver Transplantation (LTX): A Three Year Prospective Controlled Study
AM J TRANSPLANT. 2010; 10: 157-158. [Oral Communication]
Web of Science

** Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Tscheliessnigg, K; Pieber, T; Obermayer, B; Trauner, M; Fahrleitner, A Vitamin D Deficiency, Hyperparathyroidism and Bone Turnover in Patients Listed for Liver Transplantation (LTX).
AM J TRANSPLANT. 2010; 10: 350-350.-Annual Meeting of the American Society of Transplantation; MAY 2-8; San Diego, California. [Oral Communication]
Web of Science

Comment

** Dimai, HP; Svedbom, A; Fahrleitner-Pammer, A; Pieber, T; Resch, H; Zwettler, E; Chandran, M; Borgström, F Reversal in the secular trend of hip fracture incidences in Austria.
Wien Klin Wochenschr. 2010; 122(11-12): 380-381. Doi: 10.1007/s00508-010-1387-0
Web of Science PubMed FullText FullText_MUG Google Scholar

** Wagner, D; Kniepeiss, D; Iberer, F; Fahrleitner-Pammer, A; Kornprat, P; Tscheliessnigg, K Reply.
Liver Transpl. 2010; 16(10): 1221-1221. Doi: 10.1002/lt.22171 [OPEN ACCESS]
Web of Science FullText FullText_MUG

2009

Full paper/article (Journal)

** Berger, R; Shankar, A; Fruhwald, F; Fahrleitner-Pammer, A; Freemantle, N; Tavazzi, L; Cleland, JG; Pacher, R Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
Eur Heart J. 2009; 30(17): 2109-2116. Doi: 10.1093/eurheartj/ehp210 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Cummings, SR; San Martin, J; McClung, MR; Siris, ES; Eastell, R; Reid, IR; Delmas, P; Zoog, HB; Austin, M; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C; FREEDOM Trial Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
N Engl J Med. 2009; 361(8): 756-765. Doi: 10.1056/NEJMoa0809493 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR) Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009
Wien Med Wochenschr Suppl. 2009; (122): 1-34. Doi: 10.1007/s10354-009-0656-x
PubMed FullText FullText_MUG Google Scholar

** Dobnig, H; Stepan, JJ; Burr, DB; Li, J; Michalská, D; Sipos, A; Petto, H; Fahrleitner-Pammer, A; Pavo, I Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate *
J Bone Miner Res. 2009; 24(12): 1998-2006. Doi: 10.1359/jbmr.090527 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Fahrleitner-Pammer, A; Dobnig, H; Dimai, HP; Holzer, H; Benesch, T; Borchhardt, K; Cejka, D; Haas, M The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure.
Clin Nephrol. 2009; Volume 71(June): 652-659. Doi: 10.5414/CNP71652
Web of Science PubMed FullText FullText_MUG Google Scholar

** Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Pieber, TR; Obermayer-Pietsch, BM; Pilz, S; Dimai, HP; Prenner, G; Tscheliessnigg, KH; Hauge, E; Portugaller, RH; Dobnig, H Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
J Bone Miner Res. 2009; 24(7): 1335-1344. Doi: 10.1359/jbmr.090216 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Langdahl, BL; Rajzbaum, G; Jakob, F; Karras, D; Ljunggren, O; Lems, WF; Fahrleitner-Pammer, A; Bernard Walsh, J; Barker, C; Kutahov, A; Marin, F Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS).
Calcif Tissue Int. 2009; 85(6): 484-493. Doi: 10.1007/s00223-009-9299-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Pilz, S; Tomaschitz, A; Stepan, V; Obermayer-Pietsch, B; Fahrleitner-Pammer, A; Schweighofer, N; Portugaller, HR; Sourij, H; Dobnig, H; Meinitzer, A; Pieber, TR Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism.
BMC Endocr Disord. 2009; 9(2):11-11 Doi: 10.1186/1472-6823-9-11 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Abstract (Journal)

** Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Fahrleitner-Pammer, A; Bohm, BO; Marz, W 25-hydroxyvitamin D levels and association with all-cause mortality in patients with type 2 diabetes mellitus
DIABETOLOGIA. 2009; 52: 316--44th General Assembly of the European Association for the Study of Diabetes (EASD); SEP 7-11, 2009; Rome, ITALY. [Poster]
Web of Science

** Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Bohm, B; Fahrleitner-Pammer, A; Marz, W Influence of 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D status on serum parathyroid hormone levels varies at different levels of renal function
BONE. 2009; 44(2):S360-S360.-36th European Symposium on Calcified Tissue; MAY 23-27, 2009; Vienna, Austria. Doi: 10.1016/j.bone.2009.03.193 [Poster]
Web of Science FullText FullText_MUG

** Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Obermayer-Pietsch, BM; Friedl, C; Prenner, G; Tscheliessnigg, K; Dobnig, H Testosterone replacement in combination with bisphosphonate therapy in male cardiac transplant patients exerts additional benefits on bone mass: A 5-year prospective study
BONE. 2009; 44(2):S424-S424.-ECTS; June 2009; Vienna; Austria. Doi: 10.1016/j.bone.2009.03.362 [Poster]
Web of Science FullText FullText_MUG

** Lems, W; Marin, F; Langdahl, B; Karras, D; Barrett, A; Walsh, B; Fahrleitner-Pammer, A; Rajzbaum, G; Barker, C; Jakob, F FRACTURE INCIDENCE, QUALITY OF LIFE AND BACK PAIN IN WOMEN WITH OSTEOPOROSIS PRETREATED WITH BISPHOSPHONATES: 18 MONTH RESULTS FROM THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)
OSTEOPOROSIS INT. 2009; 20: 75-75. [Poster]
Web of Science

** Lems, WF; Karras, D; Langdahl, BL; Ljunggren, O; Walsh, JB; Barker, C; Fahrleitner-Pammer, A; Barrett, A; Rajzbaum, G; Jakob, F; Marin, F Fracture incidence, quality of life and back pain in women with osteoporosis and concomitant glucocorticoid use treated with teriparatide: 18-month results from the European Forsteo Observational Study
BONE. 2009; 44(2):S448-S449.-ECTS; June 2009; Vienna; Austria. Doi: 10.1016/j.bone.2009.03.421 [Poster]
Web of Science FullText FullText_MUG

** Stocker, P; Wehr, E; Schweighofer, N; Fahrleitner-Pammer, H; Dobnig, H; Pieber, TR; Obermayer-Pietsch, B Senseing polymorphisms of the calcium receptor and its possible clinical relevance
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A20-A20. [Poster]
Web of Science

** Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Pieber, TR; Obermayer-Pietsch, BM; Trauner, M; Fahrleitner-Pammer, A Vitamin D deficiency, hyperparathyroidism and bone turnover in patients listed for liver transplantation (LTX): Preliminary results of a cross-sectional study
BONE. 2009; 44(2):S400-S400.-ECTS; June 2009; Vienna; Austria. Doi: 10.1016/j.bone.2009.03.301 [Poster]
Web of Science FullText FullText_MUG

Full paper/article (Proceedings)

** Pfeifer, M; Begerow, B; Minne, HW; Suppan, K; Fahrleitner-Pammer, A; Dobnig, H Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals.
Osteoporos Int. 2009; 20(2): 315-322. Doi: 10.1007/s00198-008-0662-7
Web of Science PubMed FullText FullText_MUG Google Scholar

2008

Full paper/article (Journal)

** Langdahl, BL; Uitterlinden, AG; Ralston, SH; Trikalinos, TA; Balcells, S; Brandi, ML; Scollen, S; Lips, P; Lorenc, R; Obermayer-Pietsch, B; Reid, DM; Armas, JB; Arp, PP; Bassiti, A; Bustamante, M; Husted, LB; Carey, AH; Pérez Cano, R; Dobnig, H; Dunning, AM; Fahrleitner-Pammer, A; Falchetti, A; Karczmarewicz, E; Kruk, M; van Leeuwen, JP; Masi, L; van Meurs, JB; Mangion, J; McGuigan, FE; Mellibovsky, L; Mosekilde, L; Nogués, X; Pols, HA; Reeve, J; Renner, W; Rivadeneira, F; van Schoor, NM; Ioannidis, JP; APOSS investigators; DOPS investigators; EPOS investigators; EPOLOS investigators; FAMOS investigators; LASA investigators; ERGO investigators; for the GENOMOS Study Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.
Bone. 2008; 42(5): 969-981. Doi: 10.1016/j.bone.2007.11.007
Web of Science PubMed FullText FullText_MUG Google Scholar

** Pilz, S; Dobnig, H; Fahrleitner-Pammer, A; Polt, G; Marz, W Vitamin D deficiency: a global health problem
LABORATORIUMSMEDIZIN. 2008; 32(4): Doi: 10.1515/JLM.2008.039et
Web of Science FullText FullText_MUG

** Pilz, S; März, W; Wellnitz, B; Seelhorst, U; Fahrleitner-Pammer, A; Dimai, HP; Boehm, BO; Dobnig, H Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.
J Clin Endocrinol Metab. 2008; 93(10): 3927-3935. Doi: 10.1210/jc.2008-0784 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Rajzbaum, G; Jakob, F; Karras, D; Ljunggren, O; Lems, WF; Langdahl, BL; Fahrleitner-Pammer, A; Walsh, JB; Gibson, A; Tynan, AJ; Marin, F Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting.
Curr Med Res Opin. 2008; 24(2): 377-384. Doi: 10.1185/030079908X261087
Web of Science PubMed FullText FullText_MUG

Review

** Pilz, S; Dobnig, H; Fahrleitner-Pammer, A; Polt, G; März, W Vitamin D deficiency: a global health problem
Journal of Laboratory Medicine. 2008; 32(4): 200-208. Doi: 10.1515/JLM.2008.039
Web of Science FullText FullText_MUG

Abstract (Journal)

** Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Schweiger, M; Prenner, G; Tscheliessnigg, K.H; Piswanger-Sölkner, J.C; Dimai, H.P; Dobnig, H. Replacing testosterone in male cardiac transplant patients exerts multiple benefits on bone mass, libido and sexual activity: A 5-year prospective study.
. 2008; 23: S471 [Poster]
Web of Science

** Fahrleitner-Pammer, A; Piswanger-Solkner, JC; Obermayer-Pietsch, B; Friedl, C; Dobnig, H Testosteron substitution in a men with a heart graft with hypogonadism shows positive effects on bones metabolism, on Libido and sexual life: A 5 years long lasting controlled study
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A40-A40.-ÖGIM; 17.-21.9.2008; Graz. [Poster]
Web of Science

** Friedl, C; Dobnig, H; Piswanger-Solkner, JC; Obermayer-Pietsch, B; Fahrleitner-Pammer, A Vitamin D3 and muscular strength: Prospective analyze of 832 occupants of a nursery home in Austria
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A40-A40. [Poster]
Web of Science

** Langdahl, B; Ljunggren, O; Lems, W; Walsh, B; Barker, C; Fahrleitner-Pammer, A; Karras, D; Rajzbaum, G; Jakob, F; Kutahov, A; Marin, F Fracture incidence and changes in quality of life and back pain in women with osteoporosis treated with rhpth(I-34) (teriparatide): 18 month results from the European Forsteo Observational Study (EFOS)
CALCIFIED TISSUE INT. 2008; 82: S158-S158.-ECTS; June 2008; Barcelona. [Oral Communication]
Web of Science

** Langdahl, B; Ljunggren, Ö; Lems, W; Walsh, B.j; Barker, C; Fahrleitner-Pammer, A; Karras, D; Marin, F; Women with severe Osteoporosis treated with rhPTH(1-34)(teriparatide) improve Quality of life regardles of incident fractures: 18 month results from the European Forsteo Observational Study (EFOS).
. 2008; 23: S347 [Poster]
Web of Science

** Lems, W; Langdahl, B; Ljunggren, O; Kutahov, A; Karras, D; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Barket, C; Jakob, F; Marin, F Fracture incidence, quality of life and back pain in women with osteoporosis pretreated with bisphosphonates: 18 month results from the European forsteo, observational study (EFOS)
ARTHRITIS RHEUM. 2008; 58(9):S737-S738.-72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals; OCT 24-29, 2008; San Francisco, CA. [Oral Communication]
Web of Science

** Ljunggren, O; Fahrleitner-Pammer, A; Kutahov, A; Walsh, JB; Langdahl, B; Jakob, F; Lems, W; Rajzbaum, G; Barker, C; Karras, D; Marin, F Back Pain is Reduced in Postmenopausal Women with Severe Osteoporosis Treated with rhPTH(1-34) (teriparatide) Regardless of Incident Fractures: 18 Month Results from the European Forsteo Observational Study (EFOS).
J BONE MINER RES. 2008; 23: S347-S347.-30th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 12-16, 2008; Montreal, CANADA. [Oral Communication]
Web of Science

** Obermayer-Pietsch, BM; Meilinger, M; Wehr, E; Schweighofer, N; Fahrleitner-Pammer, A; Dobnig, H; Pietschmann, P; Kudlacek, S; Friedrich, G; Gugatschka, M Hypogonadism and bone in men: Impact of body weight in a follow-up over 4 years
CALCIFIED TISSUE INT. 2008; 82: S160-S160.-ECTS; June 2008; Barcelona. [Poster]
Web of Science

Full paper/article (Proceedings)

** Fahrleitner-Pammer, A; Herberth, J; Browning, SR; Obermayer-Pietsch, B; Wirnsberger, G; Holzer, H; Dobnig, H; Malluche, HH Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
J BONE MINER RES. 2008; 23(11): 1850-1858. Doi: 10.1359/jbmr.080610 [Poster] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

2007

Full paper/article (Journal)

** Dobnig, H; Piswanger-Sölkner, JC; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Riedmüller, G; Brueck, C; Fahrleitner-Pammer, A Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements.
J Clin Endocrinol Metab. 2007; 92(5): 1678-1686. Doi: 10.1210/jc.2006-2079 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Fruhwald, FM; Fahrleitner-Pammer, A; Berger, R; Leyva, F; Freemantle, N; Erdmann, E; Gras, D; Kappenberger, L; Tavazzi, L; Daubert, JC; Cleland, JG Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
Eur Heart J. 2007; 28(13):1592-1597 Doi: 10.1093/eurheartj/ehl505 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Gugatschka, M; Hoeller, A; Fahrleitner-Pammer, A; Dobnig, H; Pietschmann, P; Kudlacek, S; Obermayer-Pietsch, B Calcium supply, bone mineral density and genetically defined lactose maldigestion in a cohort of elderly men.
J Endocrinol Invest. 2007; 30(1): 46-51. Doi: 10.1007/BF03347395
Web of Science PubMed FullText FullText_MUG Google Scholar

** Lyles, KW; Colón-Emeric, CS; Magaziner, JS; Adachi, JD; Pieper, CF; Mautalen, C; Hyldstrup, L; Recknor, C; Nordsletten, L; Moore, KA; Lavecchia, C; Zhang, J; Mesenbrink, P; Hodgson, PK; Abrams, K; Orloff, JJ; Horowitz, Z; Eriksen, EF; Boonen, S; for the HORIZON Recurrent Fracture Trial Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture.
N Engl J Med. 2007; 357(1):nihpa40967-nihpa40967 Doi: 10.1056/NEJMe074941 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Obermayer-Pietsch, BM; Gugatschka, M; Reitter, S; Plank, W; Strele, A; Walter, D; Bonelli, C; Goessler, W; Dobnig, H; Högenauer, C; Renner, W; Fahrleitner-Pammer, A Adult-type hypolactasia and calcium availability: decreased calcium intake or impaired calcium absorption?
Osteoporos Int. 2007; 18(4): 445-451. Doi: 10.1007/s00198-006-0251-6
Web of Science PubMed FullText FullText_MUG Google Scholar

** Stepan, JJ; Burr, DB; Pavo, I; Sipos, A; Michalska, D; Li, J; Fahrleitner-Pammer, A; Petto, H; Westmore, M; Michalsky, D; Sato, M; Dobnig, H Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.
Bone. 2007; 41(3): 378-385. Doi: 10.1016/j.bone.2007.04.198
Web of Science PubMed FullText FullText_MUG Google Scholar

Abstract (Journal)

** Brueck, CC; Dobnig, H; Obermayer-Pietsch, BM; Fahrleitner-Pammer, A High serum osteoprotegerin but low bone mass in patients with peripheral arterial disease (PAD)
EXP CLIN ENDOCRINOL DIABETES. 2007; 115: S88-S88.-IOF; June 2007; Montreal Canada. [Oral Communication]
Web of Science

** Brueck, CC; Rienmuller, R; Riedmueller, G; Benedikt, M; Kovaleva, K; Gerdova, J; Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Dobnig, H Acid-base metabolism is independently correlated to bone turnover
EXP CLIN ENDOCRINOL DIABETES. 2007; 115: S88-S88.-DGE; Sakzburg. [Poster]
Web of Science

** Dobnig, H; Stepan, JJ; Burr, DB; Fahrleitner-Pammer, AF; Li, J; Sipos, A; Sato, M; Pavo, I Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate
J BONE MINER RES. 2007; 22: S28-S28.-Asbmr ; September; Honolulu Hawai. [Poster]
Web of Science

** Li, J; Burr, DB; Stepan, JJ; Dobnig, H; Fahrleitner-Pammer, A; Sipos, A; Mullamey, T; Westmore, M; Sato, M; Pavo, I Teriparatide improves bone microarchitecture in postmenopausal women previously treated with alendronate
J BONE MINER RES. 2007; 22: S28-S28.-Asbmr; September; Honolulu Hawai. [Poster]
Web of Science

** Meilinger, M; Schweighofer, N; Forjanics, A; Dobnig, H; Fahrleitner-Pammer, A; Obermayer-Pietsch, B Autoimmune thyroid disease, genetic predisposition and environment - case-control family studies
EXP CLIN ENDOCRINOL DIABETES. 2007; 115: S60-S60. [Poster]
Web of Science

** Obermayer-Pietsch, B; Gugatschka, M; Groselj-Strele, A; Goessler, W; Dobnig, H; Hoegenauer, C; Fahrleitner-Pammer, A; Renner, W Genetically defined adult-type hypolactasia and calcium balance: High amounts of lactose decrease calcium absorption
EXP CLIN ENDOCRINOL DIABETES. 2007; 115: S7-S7. [Poster]
Web of Science

** Riedmueller, G; Wascher, TC; Brueck, CC; Gerdova, J; Breuss, B; Obermayer-Pietsch, B; Fahrleitner-Pammer, A; Dobnig, H PTH - a new cardiovascular risk factor?
EXP CLIN ENDOCRINOL DIABETES. ; 115: S87-S88. [Poster]
Web of Science

2006

Full paper/article (Journal)

** Braunschweig, F; Fahrleitner-Pammer, A; Mangiavacchi, M; Ghio, S; Fotuhi, P; Hoppe, UC; Linde, C Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure.
Eur J Heart Fail. 2006; 8(8): 797-803. Doi: 10.1016/j.ejheart.2006.03.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Dobnig, H; Hofbauer, LC; Viereck, V; Obermayer-Pietsch, B; Fahrleitner-Pammer, A Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.
Osteoporos Int. 2006; 17(5):693-703 Doi: 10.1007/s00198-005-0035-4
Web of Science PubMed FullText FullText_MUG Google Scholar

** Dobnig, H; Piswanger-Sölkner, JC; Roth, M; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Sieberer, C; Fahrleitner-Pammer, A Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk.
J Clin Endocrinol Metab. 2006; 91(9):3355-3363 Doi: 10.1210/jc.2006-0460 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Herberth, J; Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Krisper, P; Holzer, H; Malluche, HH; Dobnig, H Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
Clin Nephrol. 2006; 65(5):328-334 Doi: 10.5414/CNP65328
Web of Science PubMed FullText FullText_MUG Google Scholar

** Uitterlinden, AG; Ralston, SH; Brandi, ML; Carey, AH; Grinberg, D; Langdahl, BL; Lips, P; Lorenc, R; Obermayer-Pietsch, B; Reeve, J; Reid, DM; Amedei, A; Amidei, A; Bassiti, A; Bustamante, M; Husted, LB; Diez-Perez, A; Dobnig, H; Dunning, AM; Enjuanes, A; Fahrleitner-Pammer, A; Fang, Y; Karczmarewicz, E; Kruk, M; van Leeuwen, JP; Mavilia, C; van Meurs, JB; Mangion, J; McGuigan, FE; Pols, HA; Renner, W; Rivadeneira, F; van Schoor, NM; Scollen, S; Sherlock, RE; Ioannidis, JP; APOSS Investigators; EPOS Investigators; EPOLOS Investigators; FAMOS Investigators; LASA Investigators; Rotterdam Study Investigators; GENOMOS Study The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis.
Ann Intern Med. 2006; 145(4):255-264 Doi: 10.7326/0003-4819-145-4-200608150-00005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Abstract (Journal)

** Dobnig, H; Piswanger-Solkner, C; Maier, L; Obermayer-Pietsch, B; Strele, A; Tiran, A; Brueck, C; Fahrleitner-Pammer, A Prediction of hip- and non-vertebral fractures in nursing home patients: Role of bone ultrasound and bone turnover measurements
BONE. ; 39(5):S22-S22. [Poster]
Web of Science

** Fahrleitner-Pammer, A; Dobnig, H Treatment of post-transplantation bone disease: Clinical and economic aspects
OSTEOPOROSIS INT. 2006; 17: S3-S3.-Ecceo; 25. - 28. Februar Wien; vienna austria. [Oral Communication]
Web of Science

** Fahrleitner-Pammer, A; Piswanger-Solkner, C; Obermayer-Pietsch, B; Prenner, G; Tscheliessnigg, KH; Dobnig, H Intravenous Ibandronate effectively prevents bone loss and minimizes fracture risk in patients following cardiac transplantation: A prospective randomized placebo controlled study
BONE. 2006; 39(5):S24-S25.-American Endocrine Society; June 2006; Toronto Canada. [Oral Communication]
Web of Science

** Lems, W; Rajzbaum, G; Marin, F; Fahrleitner, A; Karras, D; Langdahl, B; Walsh, JB; Ljunggren, O; Cleall, S; Tynan, A Baseline characteristics of subjects enrolled in a teriparatide observational study in Europe.
ARTHRITIS RHEUM. 54(9):S588-S588. [Poster]
Web of Science

** Obermayer-Pietsch, B; Bonelli, CM; Strele, A; Hodl, AK; Dobnig, H; Fahrleitner-Pammer, A; Kapfhammer, HP; Bonelli, RM Bone mineral density in Huntington's disease is depending on CAG repeats in the neurotrophic Huntingtin gene, but not on weight or medication
BONE. 39(5):S8-S8. [Poster]
Web of Science

** Schweighofer, N; Fahrleitner-Pammer, A From bone biopsy to copy numbers - Quantitation of bone turnover regulators via real time PCR
BONE. 39(5):S37-S37. [Poster]
Web of Science

** Walsh, JB; Cleall, S; Fahrleitner, A; Karras, D; Langdahl, B; Lems, W; Ljunggren, O; Marin, F; Raizbaum, G; Tynan, AJ Quality of life and back pain in the European Forsteo observational study - EFOS.
J BONE MINER RES. 21: S305-S305. [Poster]
Web of Science

2005

Full paper/article (Journal)

** Cleland, JG; Daubert, JC; Erdmann, E; Freemantle, N; Gras, D; Kappenberger, L; Tavazzi, L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (with Fahrleitner, A) The effect of cardiac resynchronization on morbidity and mortality in heart failure.
N Engl J Med. 2005; 352(15): 1539-1549. Doi: 10.1056/NEJMoa050496 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Dobnig, H; Sipos, A; Jiang, Y; Fahrleitner-Pammer, A; Ste-Marie, LG; Gallagher, JC; Pavo, I; Wang, J; Eriksen, EF Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.
J Clin Endocrinol Metab. 2005; 90(7):3970-3977 Doi: 10.1210/jc.2003-1703 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Fahrleitner-Pammer, A; Obernosterer, A; Pilger, E; Dobnig, H; Dimai, HP; Leb, G; Kudlacek, S; Obermayer-Pietsch, BM Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease.
OSTEOPOROSIS INT. 2005; 16(3): 319-324. Doi: 10.1007/s00198-004-1693-3
Web of Science PubMed FullText FullText_MUG Google Scholar

** Gugatschka, M; Dobnig, H; Fahrleitner-Pammer, A; Pietschmann, P; Kudlacek, S; Strele, A; Obermayer-Pietsch, B Molecularly-defined lactose malabsorption, milk consumption and anthropometric differences in adult males.
QJM. 2005; 98(12):857-863 Doi: 10.1093/qjmed/hci140 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Abstract (Journal)

** Obermayer-Pietsch, BM; Gugatschka, M; Strele, A; Fahrleitner-Pammer, A; Dobnig, H; Kudlacek, S; Pietschmann, P; Renner, W Osteoporosis and genetic disposition for primary adult lactose intolerance in men
BONE. 36: S252-S252.-2nd Joint Meeting of the European-Calcified-Tissue-Society/International-Bone-and-Mineral-Society; JUN 25-29, 2005; Geneva, SWITZERLAND.
Web of Science

** Obermayer-Pietsch, BM; Gugatschka, M; Strele, A; Reitter, S; Plank, W; Fahrleitner-Pammer, A; Dobnig, H; Goessler, W; Renner, W Lactose intolerance and skeletal calcium balance - Decreased calcium intake or impaired calcium resorption?
J BONE MINER RES. 20: S391-S391.-27th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 23-27, 2005; Nashville, TN.
Web of Science

2004

Full paper/article (Journal)

** Obermayer-Pietsch, BM; Bonelli, CM; Walter, DE; Kuhn, RJ; Fahrleitner-Pammer, A; Berghold, A; Goessler, W; Stepan, V; Dobnig, H; Leb, G; Renner, W Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures.
J BONE MINER RES. 2004; 19(1): 42-47. Doi: 10.1359/JBMR.0301207 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Short report/Letter

** Obermayer-Pietsch, BM; Bonelli, CM; Walter, D; Fahrleitner, A; Stepan, V; Dobnig, H; Leb, G; Renner, W Genetic components of lactose intolerance and community frequency
J BONE MINER RES. 2004; 19: 1747-1747. Doi: 10.1359/JBMR.040802 [OPEN ACCESS]
Web of Science FullText FullText_MUG Google Scholar

Abstract (Journal)

** Dimai, HP; Fahrleitner, A; Piswanger-Soelkner, C; Ramschak-Schwarzer, S; Obermayer-Pietsch, B; Leb, G A new hormonal upstream factor in the RANKL/OPG system? Effects of the thyroid stimulating hormone TSH in humans
J BONE MINER RES 2004 19: S414-S414.
Web of Science

** Dimai, HP; Piswanger-Soelkner, C; Fahrleitner, A; Ramschak-Schwarzer, S; Wenisch, H; Gugatschka, M; Obermayer-Pietsch, B; Leb, G Another hormonal upstream factor in the OPG/RANKL system? Effects of the thyroid stimulating hormone TSH on bone metabolism
OSTEOPOROSIS INT 2004 15: S16-S17.
Web of Science

** Fahrleitner-Pammer, A; Maier, E; Eichhorn, T; Graebe, A Postmenopausal women with osteoporosis are compliant and satisfied with daily raloxifene treatment: Results from a six-month Austrian observational study
OSTEOPOROSIS INT 2004 15: S114-S114.
Web of Science

** Fahrleitner-Pammer, A; Prenner, G; Kniepeiss, D; Tschelissnigg, K; Leb, G; Piswanger-Solkner, CJ; Obermayer-Pietsch, BM; Dobnig, H Combination therapy with ibandronate and calcitriol is effective in patients following liver transplantation: A three year prospective controlled study.
J BONE MINER RES 2004 19: S475-S475.
Web of Science

** Obermayer-Pietsch, BM; Bonelli, CM; Walter, DE; Kuhn, RJ; Fahrleitner-Pammer, A; Berghold, A; Stepan, V; Dobnig, H; Leb, G; Renner, W GENETIC DISPOSITION FOR ADULT LACTOSE INTOLERANCE AND RELATION TO BONE PROPERTIES AND FRACTURES DURING LIFETIME
CALCIFIED TISSUE INT. 2004; 74: S128-S128.
Web of Science

** Roth, M; Fahrleitner, A; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Tiran, A; Leb, G; Dobnig, H A calcium-raising mechanism lowers PTH levels and bone turnover with preservation of bone mass indices in institutionalized elderly at high risk of fracture
OSTEOPOROSIS INT 2004 15: S126-S126.
Web of Science

** Roth, M; Fahrleitner, A; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Tiran, A; Leb, G; Maier, E; Dobnig, H Institutionalized elderly type II diabetics have higher bone mass, lower bone turnover markers and PTH levels compared to non-diabetics: Evidence for decreased calcium sensing by parathyroid glands.
J BONE MINER RES 2004 19: S439-S439.
Web of Science

2003

Full paper/article (Journal)

** Fahrleitner, A; Prenner, G; Leb, G; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Portugaller, HR; Berghold, A; Dobnig, H Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation.
Bone. 2003; 32(1):96-106 Doi: 10.1016%2FS8756-3282%2802%2900926-2
Web of Science PubMed FullText FullText_MUG Google Scholar

** Fahrleitner-Pammer, A; Dobnig, H; Piswanger-Soelkner, C; Bonelli, C; Dimai, HP; Leb, G; Obermayer-Pietsch, B Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
Wien Klin Wochenschr. 2003; 115(9):291-297 Doi: 10.1007/BF03040334
Web of Science PubMed FullText FullText_MUG Google Scholar

** Hermann, J; Mueller, T; Fahrleitner, A; Dimai, HP Early onset and effective inhibition of bone resorption in patients with rheumatoid arthritis treated with the tumour necrosis factor alpha antibody infliximab.
CLIN EXP RHEUMATOL 2003 21: 473-476.
Web of Science PubMed

** Obermayer-Pietsch, BM; Lange, U; Tauber, G; Frühauf, G; Fahrleitner, A; Dobnig, H; Hermann, J; Aglas, F; Teichmann, J; Neeck, G; Leb, G Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis.
Osteoporos Int. 2003; 14(12):995-1000 Doi: 10.1007/s00198-003-1501-5
Web of Science PubMed FullText FullText_MUG Google Scholar

Abstract (Journal)

** Bonelli, CM; Walter, D; Fahrleitner, A; Solkner, CP; Dobnig, H; Linhart, W; Reitinger, T; Windhager, R; Leb, G; Obermayer-Pietsch, B Congenital hip dysplasia and disturbances of bone and connective tissue in adult female patients
BONE 2003 33: S13-S13.
Web of Science

** Dimai, HP; Piswanger-Soelkner, C; Fahrleitner, A; Ramschak-Schwarzer, S; Wenisch, H; Gugatschka, M; Leb, G Is bone metabolism affected by the human thyroid stimulating hormone TSH? Preliminary results from a clinical study in patients with TSH-suppressive thyroid hormone therapy
BONE 2003 33: S13-S13.
Web of Science

** Obermayer-Pietsch, BM; Bonelli, CM; Walter, DE; Kuhn, RJ; Fahrleitner-Pammer, A; Berghold, A; Goessler, W; Stepan, V; Dobnig, H; Renner, W; Leb, G Genetic disposition for adult lactose intolerance, calcium metabolism, bone density, and bone fractures
BONE 2003 33: S12-S12.
Web of Science

** Roth, M; Fahrleitner, A; Piswanger-Solkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H Diabetes mellitus in institutionalized patients is associated with higher bone mass measured by ultrasonography as well as lower iPTH levels and markers of bone turnover
BONE 2003 33: S14-S14.
Web of Science

2002

Full paper/article (Journal)

** Fahrleitner, A; Dobnig, H; Obernosterer, A; Pilger, E; Leb, G; Weber, K; Kudlacek, S; Obermayer-Pietsch, BM Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.
J Gen Intern Med. 2002; 17(9):663-669 Doi: 10.1046/j.1525-1497.2002.11033.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Fahrleitner, A; Prenner, G; Kniepeiss, D; Iberer, F; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Wien Klin Wochenschr. 2002; 114(15-16):717-724
Web of Science PubMed Google Scholar

Abstract (Journal)

** Bonelli, CM; Walter, D; Fahrleitner, A; Piswanger-Solkner, CJ; Dobnig, H; Linhart, W; Reitinger, T; Windhager, R; Leb, G; Obermayer-Pietsch, BM Congenital hip dysplasia and disturbances of bone and connective tissue in adult female patients
OSTEOPOROSIS INT 2002 13: S61-S61.
Web of Science

** Dimai, HP; Mueller, T; Fahrleitner, A; Hermann, J Secondary osteoporosis in rheumatoid arthritis: Early onset and effective inhibition of bone resorption after a single infusion of the TNF-alpha antibody infliximab
OSTEOPOROSIS INT 2002 13: S25-S26.
Web of Science

** Dimai, HP; Mueller, T; Fahrleitner, A; Hermann, J A single infusion of the tumor necrosis factor-alpha antibody infliximab suppresses bone resorption in patients with rheumatoid arthritis.
J BONE MINER RES. 2002; 17: S274-S275.
Web of Science

** Dobnig, H; Fahrleitner, A; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Leb, G Prospective evaluation of hip-fracture risk in institutionalized elderly by measurement of ultrasonic velocity at the radius and phalanx.
J BONE MINER RES 2002 17: S188-S188.
Web of Science

** Fahrleitner, A; Dobnig, H; Leb, G; Dimai, HP; Piswanger-Solkner, C; Bonelli, CM; Obermayer-Pietsch, B Osteoprotegerin serum levels in women: Influence of age, bone mass, bone turnover and fracture status
OSTEOPOROSIS INT 2002 13: S52-S52.
Web of Science

** Fahrleitner, A; Hofbauer, LC; Viereck, V; Obermayer-Pietsch, B; Leb, G; Dobnig, H Serum osteoprotegerin-level as a novel independent predictor of BMD changes after initiation of bisphosphonate treatment in osteoporotic patients
OSTEOPOROSIS INT 2002 13: S12-S12.
Web of Science

** Fahrleitner, A; Lauermann, T; Schreiber, B; Lewitschnig, S; Leb, G; Obermayer-Pietsch, B; Dobnig, H; Klima, G Intravenous ibandronate 1 mg every three months is an effective and well tolerated treatment option in patients with osteoporosis
OSTEOPOROSIS INT 2002 13: P42-P42.
Web of Science

** Fahrleitner, A; Prenner, G; Tscheliessnigg, KH; Leb, G; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Dimai, HP; Dobnig, H Testosterone supplementation has additional benefits on bone metabolism in cardiac transplant recipients receiving intravenous bisphosphonate treatment: A prospective study.
J BONE MINER RES 2002 17: SU423-SU423.
Web of Science

** Obermayer-Pietsch, BM; Li, W; Fahrleitner, A; Piswanger-Solkner, CJ; Bonelli, CM; Leb, G; Dobnig, H Polymorphisms of the vitamin D receptor and the collagen I alpha 1 genes as genetic risk factors for bone fractures in a high risk population in Austrian nursing homes
OSTEOPOROSIS INT 2002 13: S64-S64.
Web of Science

2001

Full paper/article (Journal)

** Neer, RM; Arnaud, CD; Zanchetta, JR; Prince, R; Gaich, GA; Reginster, JY; Hodsman, AB; Eriksen, EF; Ish-Shalom, S; Genant, HK; Wang, O; Mitlak, BH (Study group members, Leb, G; Dobnig, H; Fahrleitner, A) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
N ENGL J MED. 2001; 344(19): 1434-1441. Doi: 10.1056%2FNEJM200105103441904 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bonelli, CM; Fahrleitner, A; Walter, D; Stepan, V; Piswanger-Solkner, CJ; Dobnig, H; Leb, G; Obermayer-Pietsch, B Osteoporosis and bone metabolism in premenopausal patients with congenital hip dysplasia
BONE 2001 28: S191-S191.
Web of Science

** Dobnig, H; Fahrleitner, A; Prenner, G; Tscheliessnig, KH; Piswanger-Solkner, C; Leb, G Serum osteoprotegerin is a major determinant of bone density and vertebral fracture status in patients after cardiac transplantation
BONE 2001 28: S97-S97.
Web of Science

** Fahrleitner, A; Obernosterer, A; Pilger, E; Kudlacek, S; Hoffmann, A; Weber, K; Obermayer-Pietsch, B; Leb, G; Dobnig, H High prevalence of vitamin D deficiency and low bone mass in patients with advanced peripheral arterial occlusive disease
BONE 2001 28: S210-S210.
Web of Science

** Fahrleitner, A; Prenner, G; Leb, G; Tscheliessnigg, K; Piswanger-Solkner, C; Dobnig, H Combination therapy with ibandronate and calcitriol is effective in patients following liver transplantation.
J BONE MINER RES 2001 16: S287-S287.
Web of Science

** Mueller, TJ; Hermann, J; Fahrleitner, A; Yazdani-Biuki, B; Dimai, HP Effects of the anti-TNF-antibody infliximab on markers of bone turnover in patients with rheumatoid arthritis.
ARTHRITIS RHEUM. 2001; 44(9): S232-S232.
Web of Science

** Obermayer-Pietsch, B; Walter, D; Fahrleitner, A; Stepan, V; Kotschan, S; Berghold, A; Leb, G Bone mineral density, fracture status, bone metabolism and genetic background of osteoporosis in 350 mother-daughter pairs
BONE 2001 28: S191-S192.
Web of Science

2000

Abstract (Journal)

** Fahrleitner, A; Prenner, G; Kniepeiss, D; Tscheliessnigg, KH; Stach, L; Piswanger-Solkner, C; Leb, G; Dobnig, H Evidence for continued bone loss after cardiac transplantation - A cross sectional study in 53 patients
OSTEOPOROSIS INT 2000 11: 379-379.
Web of Science

** Fruhwald, FM; Fahrleitner, A; Maier, R; Watzinger, N; Klein, W Long-term treatment of pulmonary hypertension with inhaled iloprost and its effect on natriuretic peptides
EUR HEART J 2000 21: 596-596.
Web of Science

** Piswanger, CJ; Fahrleitner, A; Prenner, G; Kniepeiss, D; Tscheliessnigg, KH; Leb, G; Dobnig, H Liver transplantation and prevalence of osteoporosis and secondary hyperparathyroidism: First observations on osteoprotective treatment.
J BONE MINER RES 2000 15: S430-S430.
Web of Science

1999

Full paper/article (Journal)

** Fruhwald, FM; Fahrleitner, A; Watzinger, N; Dobnig, H; Schumacher, M; Maier, R; Zweiker, R; Leb, G; Klein, W N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.
Heart. 1999; 82(5):630-633 Doi: 10.1136/hrt.82.5.630 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

** Fruhwald, FM; Fahrleitner, A; Watzinger, N; Fruhwald, S; Dobnig, H; Schumacher, M; Maier, R; Zweiker, R; Klein, WW Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
Eur Heart J. 1999; 20(19):1415-1423 Doi: 10.1053/euhj.1999.1633 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Abstract (Journal)

** Dobnig, H; Friedl, G; Piswanger-Solkner, C; Berghold, A; Scherubel, C; Fahrleitner, A; Obermayer-Pietsch, B; Leb, G SOS-HIP study: Design of a 3-year hip-fracture prevention trial in institutionalized high-risk patients using ibandronate, calcium and vitamin D.
J BONE MINER RES. 14: 298-298.
Web of Science

** Fahrleitner, A; Prenner, G; Kniepeiss, D; Tscheliessnigg, KH; Dimai, HP; Leb, G; Dobnig, H Influence of cardiac transplantation (CTX) on laboratory parameters, bone mineral density (BMD) and vertebral fracture rate.
J BONE MINER RES 1999 14: S389-S389.
Web of Science

** Friedl, G; Roth, M; Timischl, C; Fahrleitner, A; Obermayer-Pietsch, B; Leb, G; Dobnig, H The effect of age on the response of bone to parathyroid hormone in rats.
J BONE MINER RES 1999 14: S308-S308.
Web of Science

↑ Top of page / Navigation